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Resumo 
 
A Malária é uma doença infeciosa causada por várias espécies de parasitas protozoários do género 
Plasmodium. Entre eles, P. falciparum é o que provoca a maior mortalidade em humanos. O parasita 
apresenta um ciclo de vida complexo, alternando entre o inseto vetor que transmite a forma infeciosa do 
parasita e o hospedeiro mamífero, no qual após a infeção o parasita passa por uma enorme replicação 
causando os sintomas da doença. Após a picada de um mosquito infetado, formas móveis denominadas 
esporozoítos são injetadas dentro do hospedeiro mamífero e viajam até ao fígado onde invadem 
hepatócitos. Após replicar dentro dos hepatócitos, milhares de novos parasitas são libertados para a 
corrente sanguínea onde invadem os glóbulos vermelhos. Durante a fase sanguínea da infeção o parasita 
passa por diversas formas de desenvolvimento, utilizando um programa de expressão génica altamente 
coordenado onde genes codificantes de proteínas para funções específicas de cada forma são ativados 
apenas quando são necessários. Ocasionalmente, algumas formas da fase sanguínea diferenciam-se em 
gametócitos, a forma sexual transmissível para os mosquitos. Durante este complexo ciclo de vida, para 
assegurar a sua sobrevivência e replicação, o parasita necessita de sequestrar nutrientes e 
micronutrientes de várias fontes dos tecidos do mosquito e do mamífero. Portanto, foi posta a hipótese 
de que os parasitas causadores de malária possuem mecanismos adequados de adaptação de maneira a 
possibilitar a utilização desta enorme variedade de recursos. O ferro é um dos micronutrientes mais 
importantes, estando envolvido em diversos processos celulares essenciais para a sobrevivência, como 
a replicação do ADN e a produção de ATP. Por outro lado, o ferro é altamente tóxico quando se encontra 
em excesso, o que implica que a sua concentração dentro das células tenha que ser mantida num intervalo 
restrito. Isto é tipicamente alcançado através da regulação da expressão de proteínas envolvidas na 
aquisição de ferro, armazenamento e metabolismo. Apesar do papel fundamental do ferro e da sua 
regulação para a sobrevivência celular, uma grande quantidade de informação básica encontra-se em 
falta no que diz respeito à forma como o parasita lida com este valioso recurso. De maneira a abordar 
esta questão, realizámos uma análise do transcriptoma total de P. falciparum durante a fase sanguínea 
em condições a curto prazo de privação de ferro e exposição a excesso de ferro. Ao identificar os genes 
diferencialmente expressos entre as diferentes condições e os respetivos controlos, pretendemos 
encontrar genes envolvidos na deteção e regulação de ferro. Os genes identificados como 
diferencialmente expressos possuem uma grande variedade de funções, desde fatores de transcrição e 
proteínas de ligação a ARN mensageiro até componentes do sistema ubiquitina-proteossoma, ARNs não 
codificantes, transferases de grupos metilo de histonas, vários transportadores e proteínas envolvidas no 
metabolismo. Estes resultados sugerem a existência de diversos níveis de regulação dos genes 
relacionados com o ferro, tanto ao nível da transcrição e da pós-transcrição, bem como ao nível da 
degradação de proteínas e mecanismos epigenéticos, indicando uma rede altamente complexa envolvida 
na manutenção da homeostasia do ferro em Plasmodium.  
 
Palavras-chave – Ferro, Plasmodium falciparum, Transcriptoma, RNA-seq 
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Abstract 
 
Malaria is an infectious disease caused by several species of protozoan parasites of the Plasmodium 
genus. Among them, P. falciparum is the one causing the greatest mortality in humans. The parasite has 
a complex life-cycle, switching between the insect vector which transmits the infective form of the 
parasite and the mammalian host, in which upon infection parasite goes through enormous replication 
causing the symptoms of the disease. Upon the bite of an infected mosquito, motile forms called 
sporozoites are injected into the mammalian host which travel to the liver and invade hepatocytes. After 
replicating inside hepatocytes, thousands of new parasites are released into the bloodstream where they 
invade red blood cells. During the blood stage of the infection the parasite goes through several 
developmental stages, using a tightly coordinated gene expression program where genes encoding 
proteins for stage-specific functions are activated only when they are required. Occasionally, some 
blood stage forms differentiate into gametocytes, the sexual stage transmissible to the mosquitoes. 
During this complex life cycle, to support its survival and replication, parasite needs to scavenge 
nutrients and micronutrients from various sources of the mammalian and insect tissues. Thus, it is 
hypothesized that malaria parasites must have adequate mechanisms of adaptation to be able to use this 
wide range of resources. Iron is one of the most important micronutrients, as it is involved in several 
cellular processes essential for survival, such as DNA replication and ATP production. On the other 
hand, iron is highly toxic when found in excess, therefore its intracellular concentrations need to be kept 
in a very narrow range. This is typically achieved through regulation of expression of proteins involved 
in iron acquisition, storage and metabolic usage. Despite the critical role of iron and its regulation for 
cell survival, a great deal of basic information is missing regarding the way that malaria parasites deal 
with this valuable resource. In order to address this question, we performed genome-wide transcriptome 
analysis of P. falciparum blood-stage by RNA-seq in conditions of short-term iron deprivation and 
exposure to iron excess. By identifying the differentially expressed genes between the different 
conditions and the respective control, we aimed to find genes involved in iron sensing and regulation. 
The genes identified as differentially expressed had a great variety of functions, from transcription 
factors and mRNA-binding proteins to components of the ubiquitin-proteasomal system, ncRNAs, 
histone methyl-transferases, several transporters and metabolism-related proteins. These results suggest 
the existence of several layers of regulation of the iron-responsive genes, both at the levels of 
transcription and post-transcription, as well as protein degradation and epigenetic mechanisms, pointing 
to a highly complex network involved in the maintenance of iron homeostasis in Plasmodium.  
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Resumo alargado 
 
A Malária é uma doença infeciosa causada por várias espécies de parasitas protozoários do género 
Plasmodium. Apesar dos esforços para a prevenção, da redução no número de casos e do investimento 
na investigação de novas terapias e vacinas anti-maláricas, esta doença continua a representar um grande 
fardo económico nas áreas endémicas. Entre as espécies existentes, P. falciparum é aquela que causa 
maior número de casos e maior mortalidade em humanos. Estes parasitas apresentam um complexo ciclo 
de vida, que se inicia quando uma fêmea de mosquito do género Anopheles (o hospedeiro invertebrado) 
injecta esporozoítos, uma forma infeciosa altamente móvel, na derme do hospedeiro mamífero 
(humanos no caso de P. falciparum) durante a sua refeição de sangue. Os esporozoítos viajam para a 
corrente sanguínea e dirigem-se ao fígado, onde invadem hepatócitos dentro dos quais se multiplicam 
em milhares de merozoítos. Estes viajam para a corrente sanguínea e invadem os glóbulos vermelhos, 
iniciando-se a fase sanguínea (assexuada) onde os parasitas apresentam um elevado grau de regulação 
da expressão génica, onde genes com funções específicas para cada forma são ativos apenas no exato 
momento em que são necessários. Durante a fase sanguínea o parasita assume diversas formas 
morfologicamente distintas: uma forma denominada anel devido à sua morfologia característica, os 
trofozoítos, altamente ativos metabolicamente, e os esquizontes. Dentro dos esquizontes formam-se 
novos merozoítos que irão invadir novos glóbulos vermelhos. Ocasionalmente, alguns merozoítos 
diferenciam-se em gametócitos feminino ou masculino, a forma sexuada infeciosa para os mosquitos. 
Quando os mosquitos picam um hospedeiro mamífero infetado, os gametócitos são transportados para 
o sistema digestivo destes onde vão dar origem aos respetivos gâmetas. O zigoto diploide móvel 
resultante da fecundação denomina-se oocineto, que invade as paredes do sistema digestivo do mosquito 
e diferencia-se num oocisto. Dentro deste ocorrem várias divisões mitóticas que darão origem a novos 
esporozoítos, que viajarão para as glândulas salivares dos mosquitos e serão transmitidos para um novo 
hospedeiro mamífero durante a próxima refeição de sangue. 
Durante este complexo ciclo de vida, os parasitas lidam com diversos recursos do hospedeiro com uma 
larga gama de concentrações, o que exige que estes possuam um sofisticado sistema de deteção e 
regulação dos mesmos. Entre estes micronutrientes, o ferro possui uma elevada importância devido ao 
seu papel central em diversos processos celulares, desde a replicação do ADN e produção de ATP até à 
participação em diversas reações enzimáticas como cofactor. Este micronutriente possui características 
de oxidação-redução únicas que lhe conferem o seu papel central em diversas reações bioquímicas. O 
facto de alternar entre dois estados de oxidação (2+ e 3+) permite-lhe associar-se com proteínas, ligar-se 
ao oxigénio e transportar eletrões, entre outras funções. Devido ao seu papel fulcral, este é altamente 
regulado na grande maioria dos organismos, desde as leveduras aos mamíferos onde diversos 
mecanismos de regulação ao nível da transcrição e da pós-transcrição atuam para manter a sua 
homeostasia, desde fatores de transcrição a proteínas que se ligam a ARN mensageiro. Apesar da sua 
elevada importância na relação parasita-hospedeiro, os mecanismos de regulação deste recurso em 
Plasmodium são ainda altamente desconhecidos. Exceções são a identificação de dois transportadores 
de ferro, o facto de o parasita regular a expressão da enzima hepática hepcidina, de extrema importância 
na regulação do ferro em mamíferos e do envolvimento do heme (grupo prostético da hemoglobina) no 
modo de ação da artemisinina, um dos medicamentos mais usados para combater a doença. Tendo estas 
evidências em conta, postulámos que estes mesmos mecanismos de regulação da expressão de genes 
envolvidos no metabolismo do ferro se encontram conservados no parasita, mantendo os seus níveis 
altos o suficiente, possibilitando a sua utilização sem que estes se tornem tóxicos. 
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Para a abordagem destas questões, as técnicas de sequenciação de larga escala de nova geração 
tornaram-se estratégias cada vez mais comuns e foram já aplicadas a diversos organismos incluindo 
parasitas do género Plasmodium. O facto de o seu genoma já se encontrar completamente sequenciado 
representa também uma vantagem neste tipo de estudos. Uma das técnicas mais utilizadas é a 
sequenciação do transcriptoma completo, ou seja, a determinação da expressão génica global de um 
dado organismo num dado momento denominada RNA-seq. Esta consiste na extração do ARN total de 
uma amostra biológica, construção de uma biblioteca de sequenciação através da conversão para ADN 
complementar, ligação de adaptadores que permitem a imobilização num suporte sólido e sequenciação 
utilizando nucleótidos artificiais que possuem um fluoróforo específico ligado. O sinal emitido será lido 
pelo sequenciador, permitindo a identificação das bases em cada posição. Esta técnica possibilita a 
abordagem de diversas questões, sendo a mais utilizada a identificação de genes diferencialmente 
expressos entre condições (organismo selvagem vs. organismo mutante ou situação controlo vs. 
tratamentos). Utilizando esta técnica, caracterizou-se o transcriptoma ao longo da fase sanguínea do 
parasita, revelando resultados muito interessantes. Ao longo desta fase do desenvolvimento ocorre uma 
onda de ativação e inibição dos genes específicos para cada forma morfológica e função específica, com 
cada gene tendo um único pico de expressão durante esta fase apenas quando é estritamente necessário.  
Pelos motivos descritos acima, propusemo-nos a identificar novos genes envolvidos na rede de 
regulação do ferro no parasita e, para tal, levámos a cabo uma experiência de sequenciação de ARN 
(RNA-seq) em diferentes condições de ferro de forma a identificar os genes diferencialmente expressos, 
que estarão potencialmente envolvidos neste processo. Para tal desenvolvemos um sistema artificial que 
introduz alterações na concentração de ferro do ambiente do parasita, nomeadamente uma condição de 
excesso e de deficiência de ferro. Após confirmarmos que o sistema era funcional e inofensivo para o 
desenvolvimento e viabilidade dos parasitas, identificámos diversos homólogos de genes envolvidos no 
metabolismo do ferro em organismos-modelo e testámos se a sua expressão era alterada pelos nossos 
tratamentos através de PCR quantitativo. Estes resultados validaram o nosso sistema, e permitiram-nos 
avançar para a experiência de RNA-seq, de maneira a caracterizar o transcriptoma de parasitas 
submetidos às diferentes condições de ferro. Para tal, utilizámos um protocolo no qual os fragmentos 
obtidos são alinhados contra o genoma de referência utilizando o software TopHat. De seguida 
procedemos à assemblagem dos transcritos utilizando o software Cufflinks e, por fim, realizámos a 
análise de expressão diferencial utilizando o software Cuffdiff. Devido ao facto de os parasitas dos 
nossos replicados biológicos, realizados em dias distintos, não se encontrarem exatamente na mesma 
forma morfológica, deparámo-nos com alguns problemas aquando do agrupamento dos nossos 
resultados. Ao compararmos os nossos dados de transcriptoma com os dados publicados ao longo da 
fase sanguínea, chegámos à conclusão que aquando da extração de ARN, os parasitas encontravam-se 
numa forma um pouco mais avançada no segundo dia quando comparando com o primeiro. A melhor 
solução foi a comparação das diferentes condições dentro de cada dia de experiência, tentando 
identificar genes com comportamentos semelhantes entre os tratamentos em cada dia. 
Os genes identificados como diferencialmente expressos entre as condições de ferro e os respetivos 
controlos possuem uma grande variedade de funções, desde fatores de transcrição, proteínas que se 
ligam a ARN mensageiro, transferases de grupos metilo de histonas, enzimas envolvidas na degradação 
de proteínas pelo complexo ubiquitina-proteossoma, diversos transportadores e até ARNs não 
codificantes. Estes resultados demonstram que o parasita não mantém a homeostasia do ferro usando 
apenas uma estratégia, mas através de uma rede de genes e mecanismos altamente complexa e regulada 
a diversos níveis, o que permite a continuação deste projeto em diversas direções altamente 
interessantes. 
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1 - Introduction  
 
1.1 – The disease and the parasite 
Malaria is an infectious disease responsible for 
approximately 500,000 deaths and 200 millions 
of infections worldwide only in 2015 (Anon 
2015). Despite the progress in research and the 
decrease in the number of cases worldwide, 
malaria is still a major health and economic 
concern in endemic areas. The disease is caused 
by several species of the protozoan parasite 
Plasmodium, which are transmitted to the hosts 
through the bite of infected Anopheles 
mosquitoes. Five Plasmodium species are 
infectious to humans: P. falciparum, P. vivax, P. 
ovale, P. malariae and P. knowlesi. Among 
these, P. falciparum is causing the greatest 
mortality (Anon 2015). Since for obvious 
reasons, in vivo studies in humans are 
complicated, species infectious to rodents like P. 
berghei, P. yoelii and P. chabaudii are widely 
used in malaria research and of major 
importance to the understanding of the parasite’s 
biology as well as disease’s pathology (Craig et 
al. 2012). 
The life cycle of Plasmodium begins when 
during a blood meal, a female Anopheles 
mosquito infected with the parasite injects 
sporozoites (motile, spindle-shaped asexual 
cells) in the host dermis (Fig. 1.1-A). Inside the 
mammalian host, the parasite goes through a 
complex life cycle. After reaching the 
bloodstream, the sporozoites travel to the liver where they invade hepatocytes (Fig. 1.1- B). Inside the 
hepatocytes each parasite will develop and replicate into thousands of new merozoites, that will be 
released into the bloodstream and infect red blood cells (RBCs) (Fig. 1.1-C). This step initiates the 
intraerythrocytic developmental cycle (IDC), in which the parasite goes through three different stages: 
ring (named after its characteristic morphology), trophozoite and schizont. In the trophozoite stage, the 
host cytoplasm is ingested and haemoglobin is proteolysed into amino acids. In the schizont stage, the 
parasite prepares for reinvasion of new RBCs by replicating DNA and forming up to 16 to 32 new 
merozoites (depending on the species) through the process of schizogony (Fig. 1.1-D). The blood stage 
is responsible for the disease’s onset and symptoms (Miller et al. 2013) and is also the target for the vast 
majority of antimalarial drugs. The IDC duration differs between Plasmodium species, being 24 hours 
for P. berghei and 48 hours for P. falciparum, for example. Plasmodium enters a sexual stage when 
some merozoites in the erythrocytes develop into male or female gametocytes (Fig. 1.1-E), which upon 
Figure 1.1 - Plasmodium life cycle: A - female Anopheles 
mosquitoes infected with sporozoites injects them in the 
mammalian host dermis. B - After reaching the bloodstream, the 
sporozoites travel to the liver where they invade hepatocytes and 
C - replicate into thousands of merozoites, which will be released 
into the bloodstream and infect red blood cells (RBCs). During 
the blood stage, the parasite goes through three different stages: 
ring, trophozoite and schizont. D - During the schizont stage, 
new merozoites are formed which will reinvade RBCs. E - The 
sexual stage begins when some merozoites develop into male or 
female gametocytes, the form infective to mosquitoes. F - Inside 
the mosquito the gametocytes differentiate in the respective 
gametes and inside the mosquito gut a zygote is formed, which 
by itself differentiates into a ookinete. G - The ookinete invades 
the midgut wall and develops into an oocyst, where several 
mitotic divisions take place, producing new sporozoites. H - This 
sporozoites migrate to the mosquito salivary glands, and are 
ready to infect a new mammalian host during the mosquito’s 
blood meal. Figure from (Portugal et al. 2011) 
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transmission to mosquito differentiate into male and female gametes, respectively (Fig. 1.1-F). Inside 
the mosquito’s gut the resulting diploid zygote will differentiate into an ookinete (a motile zygote). The 
ookinete invades through the midgut wall of the mosquito and develops into an oocyst (Fig. 1.1-G). 
Within the oocysts, several mitotic divisions take place, producing new sporozoites. These sporozoites 
migrate to the mosquito’s salivary glands and from there are injected in the bloodstream of the 
mammalian host during the next blood meal, starting the cycle again (Figure 1-H.1) (Portugal et al. 
2011).  
Across this complex life cycle the parasite must be adapted to a variability of nutrient resources, which 
represents a major challenge. Specifically concerning the micronutrients, such as iron, a tight balance 
must be achieved to meet the cellular demands but avoid toxicity. Thus, the parasite needs to maximize 
the usage of the host’s micronutrients without compromising its survival. To achieve this narrow 
homeostasis, it is expected that Plasmodium parasites, like other organisms, have mechanisms to sense, 
acquire, detoxify and metabolize iron. The complex and continuous host-parasite battle for iron has been 
an attractive research area, given the importance for the outcome of the disease. 
 
1.2 – Pathogen-host battle for iron 
It is not possible to talk about life without talking about iron. Its involvement in essential biochemical 
processes inside cells makes it one of the most important elements for almost all living organisms (Wang 
& Pantopoulos 2011; Aisen et al. 2001). In cells, iron can be found in the reduced ferrous (Fe2+) and 
oxidized ferric (Fe3+) forms. When associated with proteins, this flexible coordination and consequent 
redox reactivity allows it to bind oxygen, transport electrons and be part of enzymatic reactions as a 
cofactor on its own or as part of prosthetic groups like haem or iron-sulfur (Fe-S) clusters (Wang & 
Pantopoulos 2011). As such, iron is essential for the process of DNA replication and cellular respiration, 
among others.  
As essential for both the malaria parasite and its mammalian host, iron is one of the factors that 
contributes for the complexity of the host-pathogen relationship. Apart from two microorganisms known 
to exceptionally use manganese instead of iron (non-pathogenic lactobacilli and pathogenic Borrelia 
burgdorferi), all bacteria, fungi and protozoa require iron for survival and replication (Weinberg 2009). 
Thus throughout evolution, both host and pathogen have been contestants in an arms race for the control 
of this valuable resource (Weinberg 2009): (1) In one hand, hosts developed strategies to keep their iron 
reservoirs unavailable to their invading opponents, (2) as on the other hand pathogens developed tools 
to steal it from their hosts. Notably, this host’s property is still one of the most evolutionarily conserved 
innate mechanisms against infection (Drakesmith & Prentice 2012). 
The involvement of iron in pathogens’ growth was first described in 1944, when Schade and Caroline 
observed that raw egg white had an inhibitory effect in the growth of certain bacteria. This effect was 
only reversed when the medium was supplemented with iron, and iron alone was enough to overcome 
it (Schade & Caroline 1944). Now it is known that this inhibitory effect is due to ovotransferrin, an iron-
binding protein present in egg white. In fact, one of the main mechanisms employed by hosts to block 
iron access to pathogens is by binding it to proteins, like transferrin and ferritin. One of the most common 
pathogens’ counter attack is the use of receptors that bind these proteins (and even haemoglobin 
directly). Usually this kind of mechanism is host specific (Weinberg 2009). A mechanism that can affect 
a broader range of hosts is the use of siderophores (from the Greek “iron carrier”). These low molecular 
mass iron-binding agents scavenge iron and transport it inside cells of bacteria and fungi (Neilands 
1995). Again, some hosts developed innate immune responses against siderophores like the lipocalin 2 
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present in mammalians, that binds to enterocholine, a siderophore of enterobacteria (Flo et al. 2004). 
Additional mechanism is provided by the mammalian liver hormone hepcidin which acts as master 
regulator of dietary iron absorption and iron release from macrophages resultant from the recycling of  
senescent erythrocytes (mechanistic details in Iron sensing and regulation in mammalian cells). Also, 
hepcidin production is induced during infections, reducing the iron available for pathogens (Hentze et 
al. 2010). 
One of the most interesting findings regarding Plasmodium and iron, is the ability of blood-stage 
parasites to stimulate the production of hepcidin in a density-dependent manner, thus inhibiting 
subsequent liver stage infections (Portugal et al. 2011). As described above, the increase in hepcidin’s 
levels leads to the degradation of ferroportin, causing a redistribution of iron away from hepatocytes 
where it is needed for the development of liver stage forms. Altogether, these findings reveal two 
interesting characteristics of the parasite: 1) the ability to alter the expression of a host’s hormone, 2) 
and the presence of cross-stage competition, using iron depletion as a way to inhibit growth (blood vs. 
liver stage parasites). 
The examples described above, as well as many more that could be referenced, clearly place iron as a 
central mediator of host-pathogen interactions, as both parts of the equation continuously evolved and 
adapted in order to win the battle for iron. However, even though essential, iron can be highly toxic, as 
in aerobic conditions it promotes the formation of reactive oxygen species (ROS) and generation of 
highly reactive radicals through Fenton reaction (Aisen et al. 2001). Thus, organisms have evolved 
sophisticated strategies to sense, acquire, metabolize, and detoxify iron, fulfilling their metabolic needs 
while keeping its levels not harmful. These processes are extensively studied from the cellular level in 
organisms as simple as yeast to the systemic levels in mammals, but remain poorly investigated in case 
of Plasmodium parasites. In order to start investigating the possible mechanisms that malaria parasites 
may use to sense the iron levels and achieve homeostasis, it is necessary to understand how is this 
achieved in other organisms and investigate any possible evolutionary conservation of these pathways 
in Plasmodium. 
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1.3 – Yeast iron sensing and regulation 
Being the simple single-cell eukaryote, amenable to genetic modifications, has made the budding yeast 
Saccharomyces cerevisiae one of the most attractive models to study the cellular and molecular basis of 
iron regulation. The regulation 
of iron metabolism in yeast is 
achieved through the first line 
of regulation at the 
transcriptional level and the 
second layer of post-
transcriptional regulation. Key 
players of the iron regulation 
are three transcription factors: 
two sensing low iron levels 
(Aft1 and its paralogue Aft2), 
and one sensing high iron 
levels (Yap5). Aft1/2 regulate 
the expression of proteins 
involved in iron transport at 
the plasma membrane, 
vacuolar iron transport and 
iron metabolism, which 
combined effect will lead to 
the transport of iron into the cytosol from both intra and extracellular sources (Outten & Albetel 2013). 
On the other hand, Yap5 regulates the expression of proteins involved in iron detoxification, namely the 
vacuolar iron importer CCC1 and the iron-sulfur cluster binding proteins Tyw1 and Grx4 (Li et al. 
2011). 
Fundamental for the transcriptional iron response network in yeast are iron-sulfur clusters (Li et al. 
2012). When iron levels are high, Fe-S clusters are synthesized inside the mitochondria (Fig 1.2-1). 
These clusters are then transported to the cytosol by the mitochondrial transporter Atm1 (Fig 1.2-2), 
where they bind to glutathione (GSH), forming [2Fe-2S] bridged complexes with the monothiol 
glutaredoxins Grx3 and Grx4. These complexes, together with the cytosolic proteins Fra1 and Fra2 
travel inside the nucleus and bind to Aft1/2 (Fig. 1.2-3), leading to the dissociation of these transcription 
factors from their target DNA (Fig. 1.2-4). At the same time the iron signal inside the nucleus leads to 
Yap5 activation by a yet unknown mechanism (Fig. 1.2-5) and consequently expression of its target 
genes (Fig. 1.2-6). Among them, CCC1 acts as an iron detoxifier by importing it inside the vacuole and 
lowering the cytosolic iron pool (Fig. 1.2-7), while Tyw1, an endoplasmic reticulum (ER)-bound 
protein, sequesters iron as protein-bound Fe-S clusters (Fig. 1.2-8). Yap5 also promotes the expression 
of Grx4, which maintains the Aft1/2 inactivation and is thought to act also as an iron detoxifier by 
directly binding to it. On the other hand, when the iron levels are scarce, the Fe-S clusters do not form 
and Aft1/2 are free to bind to their dependent genes, activating them. The net effect will be the import 
of iron inside the cell and the shutdown of the mechanisms that keep it inside the vacuole and bound to 
proteins as Fe-S clusters (Outten & Albetel 2013).     
Figure 1.2 - Transcriptional iron regulation in yeast: when iron levels are high, 
iron-sulfur clusters formed inside mitochondria travel to the nucleus bound to 
monothiol glutaredoxins Grx3 and 4. Inside the nucleus they bind to the transcription 
factors Aft1/2, leading to their dissociation from the respective target genes. 
Additionally, Yap5 is activated and consequently expression of its target genes, 
namely the iron detoxifier CCC1, GRX4 and ER-bound protein TYW1. In a scenario 
of iron deprivation, the Fe-S clusters are not formed and Aft1/2 are free to bind to their 
target genes, involved in several iron transport mechanisms (Outten & Albetel 2013) 
   5 
Another layer of iron regulation is 
present in yeast, which relies on the 
mRNA-binding proteins (Fig. 1.3). 
Key to this post-transcriptional control 
are two mRNA-binding proteins Cth1 
and Cth2 (Outten & Albetel 2013). 
This mechanism can be considered as 
a fine-tune of the iron metabolism 
when iron levels are low, as its impact 
is much smaller when compared to the 
transcriptional control of Aft1/2 and 
Yap5. In fact, the expression of Cth1 
and Cth2 is directly dependent of the 
action of Aft1/2. These two proteins 
transport the respective target mRNAs 
to the cytosol and promote their 
degradation, by binding to AU-rich 
elements (AREs) present in the 3’ UTR 
(untranslated region) (Martínez-Pastor 
et al. 2013). The proteins under this 
control are involved in Fe-rich 
pathways, like respiration, 
tricarboxylic acid (TCA) cycle, haem 
biosynthesis, amino acid, sterol and 
fatty acid metabolism, and mitochondrial Fe-S cluster biogenesis. Interestingly, both Cth1 and Cth2 
have AREs in their own 3’ UTR, allowing a precise cross and auto-regulation of their expression (Fig 
1.3) (Outten & Albetel 2013). 
 
1.4 – Iron sensing and regulation in mammalian cells 
In mammals, the vast majority of iron is present inside the RBCs as part of haem, the prosthetic group 
of haemoglobin (De Domenico et al. 2008). Additional iron storages are macrophages and the 
myoglobin of muscles, while excess iron in stored in the liver (Wang & Pantopoulos 2011). As mammals 
do not possess mechanisms for iron excretion, the control of iron levels depend on the regulation of 
dietary uptake in duodenum and macrophage recycling of erythrocytic iron. Iron is absorbed from the 
intestinal lumen to enterocytes by DMT1 (Divalent Metal Transporter 1) (Gunshin et al. 1997) or as 
haem-bound by haem transporters, and further from enterocytes to the bloodstream by ferroportin. 
Macrophages, which recycle iron by consuming senescent RBCs, also have ferroportin as the iron 
transporter to the bloodstream. Once found in the plasma, iron binds to the glycoprotein transferrin, 
which serves as a vehicle that transport iron to all the tissues. Transferrin-bound iron is then taken up 
by receptor-mediated endocytosis upon binding to transferrin receptor 1 and 2 (TfR1 and TfR2). While 
TfR1 is ubiquitously expressed, TfR2 is predominantly expressed in the liver. Once it is found in the 
cytosol, iron is transported into the mitochondria to be used for synthesis of haem and Fe-S clusters, 
while the excess is stored in ferritin, a cytosolic protein. The efflux of iron from enterocytes and 
macrophages is tightly regulated by the hepatic hormone hepcidin, which upon inflammation or high 
iron levels targets ferroportin to degradation. On the other hand, hepcidin expression is repressed by 
iron deficiency and increased erythropoiesis (Hentze et al. 2010).  
Figure 1.3 - Post-transcriptional iron regulation in yeast: the two mRNA-
binding proteins Cth1 and Cth2, whose expression is activated by Aft1/2 
upon iron deprivation, bind to AU-rich elements (AREs) in the 3’ UTR of 
the respective mRNAs and transport them to the cytosol where they will be 
degraded. These genes are involved in several iron utilizing pathways. 
Additionally, Cth1 and Cth2 themselves have AREs in their own 3’ UTR, 
allowing a precise regulation of their expression.   (Outten & Albetel 2013) 
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This systemic regulatory 
system is coordinated with an 
intracellular one, that makes 
use of mRNA-binding 
proteins. The two proteins 
involved in this system are 
iron regulatory proteins 1 and 
2 (IRP1 and IRP2). While 
IRP2 acts only as a mRNA-
binding protein, IRP1 also 
has aconitase activity 
(Wilkinson & Pantopoulos 
2014). Aconitase is an 
enzyme of the TCA cycle that 
catalyses the stereo-specific 
isomerization of citrate to 
isocitrate via cis-aconitate 
(Beinert & Kennedy 1993). 
The dual function of this 
protein is due to the assembly 
of a [4Fe-4S] cluster, which is absent in IRP2. When iron levels are low, these two proteins act in the 
respective targets by binding to highly conserved hairpin structures of 25-30 nucleotides, the iron 
responsive elements (IREs). The major difference between this system and the one present in yeast relies 
on the localization of the IREs in the target gene’s mRNA. Depending if the IREs is located in the 3’ or 
the 5’ UTR, the binding of the IRPs will lead to the stabilization or translational blocking of the target 
mRNA, respectively (Fig. 1.4) (Wilkinson & Pantopoulos 2014). When iron levels are low, both IRPs 
bind to the 5’ UTR of both subunits of ferritin (H-ferritin and L-ferritin), blocking its translation, and to 
the 3’ UTR of transferrin receptor 1, protecting the mRNA from endonucleolytic degradation. The 
combined effect of blocking iron storage inside ferritin and transport of iron by transferrin upon binding 
to TfR1 will restore the iron levels inside cells. In the opposite scenario, i.e., iron overload, IRP1 binds 
Fe-S cluster and acquires aconitase activity and consequently loses its mRNA binding activity, while 
IRP2 is degraded. The absence of IRP1 and IRP2 allow the translation of ferritin and consequent storage 
of iron excess, while the mRNA for TfR1 becomes vulnerable for endonucleolytic degradation. The 
drop in the number of transferrin receptors decreases the cellular iron transport, and consequently 
restores normal iron levels. More recently, IRE/IRP regulatory network was investigated on the genome-
wide level by immunoprecipitation of ribonucleoprotein complexes containing IRP and bound mRNA 
followed by microarray analyses (Sanchez et al. 2011). In this way, further 35 novel target mRNAs that 
bind both IRP1 and IRP2 were identified, leading to a much more comprehensive understanding of the 
IRP regulon in mammalian cells. 
 
1.5 – Iron in Plasmodium: what do we know? 
For all the reasons described above, it is clear that iron possesses a central role for living organisms, and 
Plasmodium is not an exception. Despite that, it is surprising how little is known concerning the 
mechanisms employed by the parasite to deal with this resource. Using iron chelating compounds, it has 
been shown that iron is essential for the survival of the parasite across the life cycle: from gametocytes 
and blood stage forms (Ferrer et al. 2012) to liver stage forms (Stahel et al. 1988).  
Figure 1.4 - Post-transcriptional regulation by IRPs/IREs in mammals: the 
mRNA-binding proteins iron regulatory proteins 1 and 2 (IRP1 and IRP2) block or 
promote their target mRNAs translation by binding to iron responsive elements (IREs) 
in the 5’ or 3’ UTR respectively. Upon iron deprivation, they block the translation of 
both ferritin subunits and stabilize transferrin receptor 1 (TfR1), while upon iron 
excess they promote the unimpeded translation of the ferritin subunits and promote the 
endonucleolytic degradation of TfR1 mRNA. Figure from (Wilkinson & Pantopoulos 
2014). 
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So far, two iron transporters have been identified in Plasmodium: ZIP domain-containing protein 
(ZIPCO) (Sahu et al. 2014) and Vacuolar Iron Transporter homologue (VIT) (Slavic et al. 2016). ZIPCO 
was shown to localise to the plasma membrane of rodent P. berghei parasites, and to be predominantly 
expressed during the liver stage development of parasites. Its gene deletion greatly impairs the parasite’s 
development in hepatocytes, but has no effect on the ability to infect mosquitoes and multiply in mouse 
blood (Sahu et al. 2014). VIT is a homologue of yeast’s CCC1 and plant Vacuolar Iron Transporters 
that is expressed in Plasmodium throughout the life cycle and provides an iron detoxification 
mechanism, by removing iron excess from cytosol (Slavic et al. 2016). As it happens with ZIPCO, VIT 
is not essential during the entire life cycle, which indicates the presence of compensatory mechanisms 
to transport and detoxify iron. 
Haem biosynthesis is directly dependent on iron, and has been shown recently to play a role in the 
mechanism of action of artemisinin, the main drug used to treat the disease. During the intraerythrocytic 
developmental cycle the parasite degrades host haemoglobin, producing amino acids and releasing free 
haem, which is sequestered in the crystal hemozoin. The genetic down modulation of falcipains 2 and 
3, two cysteine protease haemoglobinases, confers artemisinin resistance in rings, confirming the role 
of haemoglobin degradation in artemisinin’s mode of action (Xie et al. 2016). It seems that haem 
synthesized by the parasite during the ring stage and resultant from haemoglobin degradation in later 
stages, rather than free iron, is the main activator of artemisinin (Wang et al. 2015). 
It is intriguing that even though degradation of haemoglobin leading to the release of haem plays such 
a central role in the survival of blood stage parasites, we still do not know what exactly is the source of 
iron that parasites use during their replication. Most of the release haem is converted into inert crystal 
hemozoin, preventing toxicity of excess haem. Evidence so far suggests that parasites cannot 
enzymatically degrade this haem, which would suggest that it could not serve as a source of iron (Sigala 
et al. 2012). Even less studied and known is the case of parasite iron metabolism at their liver stage of 
development. 
No one can ignore the impact iron has in every aspect of Plasmodium biology, from its own survival 
and replication to all the interactions established with the host. The need for sensing and consequently 
adapting to iron levels must be of major importance to the parasite, and it wouldn’t be a surprise to 
observe a remodelling of gene expression in response to this resource, as it happens in yeast and 
mammalian cells. By using one of the most recent and advanced approaches to study genome-wide 
responses in organisms, carefully described in the next section, this work will try to provide new insights 
in the complex role of iron for Plasmodium parasites. 
 
1.6 – Welcome to the omics’ era! 
In the past two decades, the development of high-throughput sequencing technologies and 
bioinformatics tools to analyse the data generated had a major impact in science. The “omics” fields 
provided different layers for studying cellular and molecular systems: genes (genomics), mRNAs 
(transcriptomics), proteins (proteomics) and metabolites (metabolomics) can now be profoundly 
studied. By using one or more of these approaches it is possible to characterize an organism in a highly 
dynamic way. Genomes from several organisms are already fully sequenced (including P. falciparum 
(Gardner et al. 2002)), and many more will follow in the next few years, providing an invaluable 
resource for the studies of living organisms.  It is also possible to address global responses to specific 
conditions, for example by using transcriptomics to compare the gene expression between a wild-type 
and a mutant organism, or proteomics to compare the protein expression between control and treated 
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condition (administration of a drug or toxic compound, different temperatures or pH levels, etc.). These 
kinds of studies are starting to become widely used in many areas of research, from evolutionary biology 
to biomedical sciences, and are of great importance to help solving fundamental questions like the 
genetic basis of adaptation and the evolution of gene expression profiles, among others. 
 
1.6.1 – Our approach: RNA-seq! 
Whole transcriptome shotgun 
sequencing, a.k.a RNA-seq, is an 
approach that allows transcriptome 
profiling using deep-sequencing 
technologies (Chu & Corey 2012). 
The transcriptome is commonly 
defined as the complete set of 
transcripts and their abundance, in a 
cell, in a particular stage and 
condition (Wang et al. 2009). It is 
becoming widely used due to the 
advantages compared to DNA 
microarrays, namely the lower 
amount of material needed, lower 
background noise, higher 
sensitivity, and the fact that it doesn’t need prior knowledge about the organism’s genome sequence 
(Wang et al. 2009).  
A typical RNA-seq protocols involves the following 
steps: total RNA isolation, ribosomal RNA 
depletion (as it represents about 95% of total RNA), 
cDNA synthesis (library preparation), ligation of 
adapters to each cDNA molecule to allow the 
binding to a solid support (cluster generation) and 
parallel sequencing of millions of locally amplified 
cDNA fragments via sequencing by synthesis (in 
this step, details vary according to the platform 
used) (Hoeijmakers et al. 2013). In our particular 
case, the platform used was Illumina. After the 
cDNA synthesis, cDNA molecules are bound to 
specific primers, which allows the binding to a solid 
support, where amplification occurs by bridge PCR. 
This is called solid-phase amplification (Fig. 1.5) 
(Metzker 2010). After this step, clonally amplified 
fragments are sequenced by cyclic reversible 
termination (CRT). In this phase, each nucleotide 
(A, T, C, G) has a specific fluorophore incorporated, 
as well as a terminating group. Upon binding of each 
nucleotide, mediated by a DNA polymerase, the 
incorporation is terminated and the signal in that 
position is recorded (Fig 1.6) (Metzker 2010). As 
Figure 1.5. – Solid-phase amplification: library is loaded into a flow cell and 
fragments hybridize to the surface. Each fragment is amplified by bridge PCR into 
a clonal cluster Figure from (Metzker 2010). 
Figure 1.6. – Cyclic reversible termination: fluorescently 
labelled nucleotides are added and the first base is 
incorporated. The flow cell is imaged and the emission from 
each cluster is recorded Figure from (Metzker 2010). 
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the four nucleotides are present during each sequencing cycle, natural competition between them 
minimizes incorporation bias. Also, the 
separation between incorporation and 
recording of the signal increases the 
precision of the technique. 
Another advance regarding this 
technology is the use of paired-end 
reads. This involves sequencing each 
end of the cDNA fragments in the 
library and aligning the forward and 
reverse read as read pairs. Because the distance between each pair is known, alignment algorithms can 
use this information to map the reads more precisely (Fig. 1.7) (Illumina 2015). 
There are several type of questions that might be addressed using RNA-seq, from the detection of 
alternative splicing events (Griffith et al. 2010), detection of non-protein coding RNAs (Broadbent et 
al. 2015), detection of fusion genes (Maher et al. 2009), among others. Despite that, the most common 
and straightforward application of RNA-seq is still the quantification of gene expression between 
samples, in order to find differentially expressed genes (Oshlack et al. 2010). As referenced above, 
several variables might be tested as factors affecting gene expression, from treatments with drugs to 
alterations in environmental conditions, or even compare the transcriptome of a wild-type and a mutant 
organism of the same species. Also, there are studies addressing transcriptomic changes in response to 
iron: it is described that yeast remodels its transcriptome in response to iron deprivation, switching from 
iron-dependent to iron-independent metabolic pathways by the activation of the iron independent 
transcription factor Aft1p (Shakoury-Elizeh et al. 2004) . In a subsequent paper, also using yeast in an 
iron deprivation condition, the authors identified 100 and 42 genes up and down-regulated, respectively. 
These represents around 2% of the genome, and most of them were associated with iron uptake and 
transport mechanisms (Jo et al. 2009). These works clearly show the potential of these approaches to 
study iron responses at a genome-wide level. Additionally, in a study from Moyerbrailean et. al, the 
authors analysed the transcriptomic profile by RNA-seq in response to 23 environmental perturbations 
(including changes in iron levels) in lymphoblastoid cell lines (Moyerbrailean et al. 2015), showing that 
these techniques will become common practice in several laboratories, due to the optimization of 
sequencing protocols and the decrease in cost.  
These gene expression profiling studies are targets of great interest for studying pathogen’s responses 
to compounds, in order to find potential drugs. Indeed, this approach was already used in Plasmodium 
falciparum, both using microarrays (Hu et al. 2010; Siwo et al. 2015) and RNA-seq (Shaw et al. 2015). 
The fact that these parasites are easily maintained in continuous culture (Trager & Jensen 1976), 
facilitates in vitro drug testing.  
 
 
1.7 – Plasmodium falciparum blood stage transcriptome: a unique gene regulation cascade 
mechanism among eukaryotes 
As described in the first section, the parasite goes through a complex sequence of events during the 48h 
blood stage, assuming three different stages with particular morphological and metabolic features: ring 
(0-18h), trophozoite (18-30h) and schizont (30-48h). In order to complete this cycle and consequently 
establish an infection in the human host, it must have a tight temporal regulation of transcription, as 
Figure 1.7. – Paired-End Reads: both ends of the cDNA fragment are 
sequenced, providing a read pair to be aligned to the reference sequence 
Figure from (Illumina 2015) 
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each stage is present within a specific window of time. This has been a fundamental question in the 
malaria parasite research, as it would deeply improve the knowledge of its biology and might open doors 
for the development of stage specific drugs or vaccines. Additionally, the gene expression regulatory 
elements themselves might be good targets for new antimalarial drugs, as the deregulation of the 
mechanisms that control the developmental cycle would prevent parasite growth and potentially 
eliminate it. The sequencing of P. falciparum genome was a major tool to elucidate the molecular 
mechanisms behind these developmental events. The 22.8 Mb genome encodes around 5400 genes and 
is one of the most AT-rich genomes among living organisms. It is organized in 14 nuclear linear 
chromosomes, a circular apicoplast genome and a linear mitochondrial genome (Gardner et al. 2002). 
While the nuclear genes’ expression is not coregulated, the plastid genes are organized in polycistronic 
units and highly coregulated (Bozdech et al. 2003).  
Indeed, the first study of P. falciparum IDC transcriptome revealed amazing results. Using microarrays, 
Bozdech and Llinás deeply characterized the transcriptome during the entire IDC, by measuring mRNA 
levels of highly synchronized parasites during the 48 hours at a 1-hour time scale resolution (Bozdech 
et al. 2003). With these results, they observed that around 80% of the genes expressed have changes in 
transcript abundance across the IDC. More surprising is the fact that the parasite exhibits a continuous 
cascade of gene expression, with most of the genes being expressed only once during the IDC, with its 
maximum expression level correlating with the specific function of the product produced (Fig. 1.8 left) 
(Bozdech et al. 2003). During the first half of the IDC, equivalent to ring/early troph stages, genes 
involved in general cellular mechanisms are activated, i.e., transcription, translation, glycolysis and 
ribonucleotide synthesis (Fig. 1.8 left B-E). With the progression to the trophozoite stage comes the 
expression of genes involved in several metabolic pathways. This result is expected, as the trophozoite 
stage is the most metabolically active. The class of genes characteristic of this stage include DNA 
Figure 1.8. – P. falciparum IDC transcriptome: 
(left) - In panel A, each line represents a gene, 
with the correspondent level of expression across 
the IDC. On the left side of the figure is depicted 
the characteristic stage aligned to the genes with 
peak expression at that stage. Panels B to M 
depict specific biochemical processes, organized 
chronologically as they occur during IDC. 
(Bozdech et al. 2003); (right) – IDC of 3 strains 
of P. falciparum shows the conservation of the 
gene expression cascade (Llinas et al. 2006)  
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replication machinery, TCA cycle and deoxynucleotide synthesis (Fig. 1.8. left F-H), showing the 
coordinated transcription of genes involved in DNA synthesis and the precursors required for this 
process. Also, these findings clearly separate deoxynucleotide production as a trophozoite-process and 
ribonucleotide production as a ring-process. The shift to schizont stage induces genes involved in 
proteasome and plastid genome (Fig. 1.8. left I-J), indicating a role of protein degradation in the 
development of the parasite. On the other hand, the activation of plastid genome clearly shows the 
expression of parasite-specific mechanisms with the progression of IDC. In the final part of IDC, genes 
involved in host invasion are activated, as new merozoites are produced. These categories include 
merozoite invasion and actin myosin motility (Fig. 1.8. left K-L). The latter shows the implication of 
action and myosin in the remodelling of host cells, allowing the successful invasion. With the successful 
merozoite invasion and consequent formation of new rings, comes the expression of early ring 
transcripts (Fig. 1.8. left M).  
In a subsequent work, Llinás and Bozdech characterize the transcriptome of two additional P. 
falciparum and were able to show that this pattern was conserved between them (Figure 1.8. right), 
clearly placing it as a specific parasite phenomena (Llinas et al. 2006). Le Roch et al. observed similar 
results in their study of the transcriptome characterization of nine different stages of the parasite 
(including asexual IDC stages), like the high percentage of genes that are expressed only once during 
the IDC, the shift of functions from ring and trophozoite to schizont and the fact that almost half of the 
genes are cell cycle regulated (K G Le Roch et al. 2004). 
The big question imposed by these results is how is this gene expression cascade across the IDC 
regulated. There are several evidences suggesting post-transcriptional and translation control 
outweighing transcriptional control: first, the reduced number of genes encoding transcription factors 
and transcription associated proteins in P. falciparum genome (Coulson et al. 2004) (despite the 
identification of the Apicomplexan AP2 family of DNA binding proteins as potential transcription 
factors controlling development) (Painter et al. 2012). Second, the significant delay observed between 
mRNA and protein abundance also imply mechanism of post-transcriptional and translational control 
(Karine G Le Roch et al. 2004; EM et al. 2014). However, Caro et al. recently observed that transcription 
and translation are closely coupled for most genes (Caro et al. 2014), giving strength to the debate. 
Third, several studies suggest that mRNA-binding proteins have a huge impact in gene expression 
regulation of the parasite: Reddy et al. performed a bioinformatic identification and annotation of 189 
putative RNA-binding proteins of the parasite (Reddy et al. 2015). Additionally, in a very recent work, 
Bunnik et al. made a deep comparative genomics study complemented with experimental validation of  
the “mRNA-bound proteome”, being able to observe that P. falciparum has a higher number of genes 
encoding mRNA-binding proteins when compared to other organisms (Bunnik et al. 2016). Among 
these, PfAlba1 seems to have an important role in regulating time translation during IDC, as it binds to 
several mRNAs changing their steady state levels (Vembar et al. 2015). Finally, epigenetic mechanisms 
seem to play a role in transcriptional control of the parasite: Rovira-Graells et. al observed that the 
histone mark H3K9me3 (which promotes the formation of heterochromatin in higher eukaryotes) has a 
function in gene repression in the parasite (Rovira-Graells et al. 2012). 
All the findings described above illustrate the importance of deep understanding of the regulation of the 
transcriptome across the IDC. However, it is also clear that these studies unveiled more questions than 
answers: what are the exact molecular pathways regulating gene expression during IDC? Does the 
parasite sense its surrounding environment (human host) in order to “decide” when it should start the 
development to the subsequent stage, or is this a stochastic event? Does it have any kind of quorum-
sensing mechanism, proliferating adequately to the density of parasites in order to survive inside the 
human host without killing it? Also intriguing is the bridge to the host-pathogen battle for resources: are 
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there any mechanisms of sensing and consequent gene expression regulation in response to the host 
nutritional status? This topic will be particularly addressed in this thesis, making use of the tools 
provided by the boost of high-throughput sequencing with special emphasis in iron. Does the parasite 
have mechanisms of transcriptional and post-transcriptional regulation of gene expression in response 
to iron like yeast and mammalian cells? If it does, which genes are target of this regulation: iron 
transporters, detoxifiers or Fe-S cluster proteins? We hope to be able to start answering these (and many 
more) questions, which are of great relevance for the better understanding of the basic biology of the 
parasite, allowing for the development of broader (in terms of activity across the life cycle stage) and at 
the same time, more specific (in terms of targeting only the parasite and not the host) anti-malarial 
strategies. 
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2 – Thesis aims 
 
As iron is a micronutrient with a major role in infection, being essential for both the pathogen and the 
host, the main objective of this work was to identify genes involved in iron sensing and regulation in 
Plasmodium falciparum, the parasite responsible for the most severe form of Malaria in humans. To 
address that, putative homologues of iron-responsive genes in model organisms were identified in P. 
falciparum and it was tested how their expression levels were affected by changes in the iron 
concentration of the parasite environment. However, since no homologues of the main iron-sensing 
proteins could be identified in Plasmodium, an RNA-seq experiment was performed in order to identify 
transcriptomic changes in P. falciparum exposed to iron excess and iron depletion condition. In this 
way, by identifying differentially expressed genes between the conditions tested through a genome-wide 
approach, we intend to identify new mechanisms of iron-sensing and regulation of the complex iron 
metabolic network in the malaria parasite. 
 
 
3 – Methods 
 
3.1 BLAST (Basic Local Alignment Search Tool) and Multiple Alignment 
BLAST searches were performed in the NCBI website (https://blast.ncbi.nlm.nih.gov/Blast.cgi) using 
the protein blast (blastp) tool with default parameters.  After the BLAST search, multiple alignments 
were performed using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) with default 
parameters between the potential homologue in P. falciparum and the one used in the BLAST search. 
All protein sequences were provided in FASTA format (retrieved from Uniprot or PlasmoDB for S. 
cerevisae and S. pombe or P. falciparum genes, respectively). In order to quantify the gene expression 
by qPCR, primers were designed using the PrimerQuest tool in the IDT website (http://eu.idtdna.com/). 
 
3.2 – Preparation of biological samples 
3.2.1 – P. falciparum in vitro culture 
P. falciparum 3D7 strain blood stage parasites were cultured using standard protocol for in vitro culture 
(Trager & Jensen 1976). The parasites were kept in a culture flask in malaria complete medium (MCM) 
and blood diluted to 5% haematocrit. The incubator’s temperature was 37°C, the O2 and CO2 percentage 
4 and 5, respectively. 
Medium was changed every day or every two days, depending on the parasitemia (percentage of infected 
RBCs). Smears were made regularly to keep track of parasitemia and dilute the culture with MCM and 
blood if needed. Levels of parasitemia higher than 10% might lead to culture’s crash and consequent 
death of the parasites.  
 
   14 
3.2.2 – Giemsa staining of smears 
An aliquot of P. falciparum culture was transferred to a microcentrifuge tube and centrifuged at 2000 
rpm for 1 min. Then, 2 l of pelleted RBCs were aspirated and smeared on a microscope slide. Smears 
were dried for 1-2 min, fixed in methanol for 10 seconds and stained in Giemsa Stain modified solution 
(Sigma) diluted 5% in Giemsa buffer for 5-10 minutes. Parasitemia was counted in the optical 
microscope under the 100x objective (with the use of immersion oil). 
 
3.2.3 – MCM composition 
 500 ml RPMI Medium 1640 (1X) [-] L-Glutamine (gibco by Life Technologies) 
 12.5 ml HEPES Buffer Solution (1M) (gibco by Life Technologies) 
 500 l Gentamicin 50 mg/ml (gibco by Life Technologies) 
 5 ml L-glutamine 200mM (100X) (gibco by Life Technologies) 
 50 ml Albumax II solution (preparation below)  
3.2.4 – Albumax II solution composition 
 5.2 g RPMI 1640 powder (gibco by Life Technologies) 
 500 l Gentamicin 50 mg/ml (gibco by Life Technologies) 
 2.98g HEPES (gibco by Life Technologies) 
 1g Glucose 
 1.67g NaHCO3 
 0.1 g Hypoxanthine 
 25g Albumax II (gibco by Life Technologies) 
 Distilled water was added up to 500ml, and the solution was filter sterilized 
 
3.2.5 – Washing of Human Blood 
Total human blood was centrifuged at 2000 rpm for 5 min and the supernatant was removed in order to 
deplete serum and leukocytes. Then, pelleted blood was washed in PBS 1x up to 50 ml for two times. 
Washed blood was centrifuged and ressuspended in MCM at a ratio 1:1 and kept at 4°C.  
 
3.2.6 – Thawing of glycerolyte-frozen parasites 
A frozen vial of P. falciparum 3D7 was removed from cold storage and thawed at 37°C for 1-2 min. 
After thawing, blood was transferred to a 50 ml falcon tube with a sterile pipette and blood volume (V) 
was measured. Then, 0.1 x V of 12% NaCl in distilled water was added to the blood slowly, dropwise, 
while shaking the tube gently and the tube was let to stand for 5 minutes. Then, 10 x V of 1.6% NaCl in 
distilled water was added to the blood slowly, dropwise, swirling the tube and blood was centrifuged at 
500 g at 20°C for 5 min. Supernatant was aspirated and 10 x V of MCM was added slowly, dropwise, 
while shaking the tube. Blood was centrifuged at 1500 rpm at 20°C for 5 min and supernatant was 
aspirated. Pelleted blood cells were ressuspended in MCM with 5% haematocrit and transferred to a 
culture flask. Smears were made and medium was changed every day until the parasites become visible 
by Giemsa staining, which happened around day 3. 
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3.2.7 – Sorbitol synchronization 
Parasites should be taken when they are mostly at ring stage (they must not be later than 10 to 12h post-
invasion when the sorbitol treatment is done). Culture was transferred to a falcon tube and centrifuged 
at 600 g for 5 min. Then, supernatant was removed and 10 ml of sorbitol 5% in distilled water was 
added. Tube was left for 10 min at room temperature, shaken 2 or 3 times and centrifuged at 600 g for 
5 min. Blood pellet was washed in PBS, centrifugation was repeated and blood was washed in MCM. 
Finally, blood was centrifuged and ressuspended in MCM diluted to 5% haematocrit (as previously 
described). In order to keep parasites synchronized, the procedure was repeated after 1 cycle 
(approximately 48h). 
 
3.2.8 – Iron Treatments 
Iron excess conditions was achieved by adding FeSO4 (100 mM stock in 0.1M HCl) to the medium to a 
final concentration of 200 M. Note: in order to keep Fe in the 2+ form (the one permeable to biological 
membranes) ascorbic acid (Aa) solution (stock 100 mM) was also added to a final concentration of 200 
M. In order to be able to make valid comparison, a condition with only ascorbic acid added to the 
medium was always present. Iron deficiency condition was achieved by adding deferoxamine (DFO) to 
the medium (stock 50 mm) to a final concentration of 20 M. To simplify the nomenclature, iron excess 
treatment will be referred as Fe, while iron depletion will be referred as DFO. Each condition had a 
correspondent control: for Fe it was a condition with ascorbic acid added to the medium (referred as Aa) 
and for DFO it was a control with normal MCM without any treatment (referred as Control). 
 
3.2.9 – PhenGreen assay 
In order to make sure that the treatments were changing the iron levels, the labile iron pool of the iRBCs 
was measured by flow cytometry using the PhenGreen fluorescent dye, after 6 and after 24 h incubation 
(Note: all the samples were processed in parallel, so the treatments were set up accordingly, i.e., 24 hour 
treatments were first set up and after 18 hours 6 hour treatments were set up. In this way, both treatments 
finished at the same time). 
In a plate, each treatment was set up in duplicate in order to analyse both time-points as described above. 
The parasites were mostly in the trophozoite stage (sorbitol synchronized) with a parasitemia of 1-2% 
by the time of the collection for the analysis. When the incubation time was finished, the plate was 
centrifuged at 500 g for 5 min and medium was removed. Syto61 staining solution was prepared for 
DNA staining as well as PhenGreen solution in RPMI medium without FBS at 0.5M and 10M 
respectively. This step is of major importance as FBS might quench fluorescence. After 1 hour 
incubation, samples were washed 2 times in PBS. Finally, stained cells were analysed in a BD Accuri 
C6 flow cytometer, where PhenGreen-positive cells were detected in FL1-A channel and Syto61-
positive cells in FL4-A channel. The geometric mean of PhenGreen fluorescence for the FL1-A, FL4-
A positive subset was determined for all samples. 
 
3.2.10 – Viability assay 
Each treatment was set up (Fe + Aa, Aa and DFO) as well as a control situation without any treatment 
in a plate (as described above). The parasites were mostly in trophozoite stage (sorbitol synchronized) 
   16 
with a parasitemia of 1-2%. After 6 hour smears were made, then the plate was centrifuged at 500 g for 
5 min and the medium removed. Cultures were replaced with MCM without any treatment, and after 24 
hour smears were repeated. 
 
3.2.11 – RNA extraction 
Before starting, centrifuge was cooled down at 4°C for the Tryzol phase separation. Gloves were always 
used and RNAse free conditions were followed, namely tips, solutions, etc. Until the first wash work 
was performed under the chemical hood and waste discarded into halogenated residues due to the use 
of chloroform.  
Cultures were transferred to a falcon tube and centrifuged at 500 g for 5 min. The total volume of the 
blood pellet was calculated for each sample and Tryzol LS was added at a 1:3 ratio (for example, for 
200 l of blood 600 l of Tryzol LS were added). These mixtures were quickly ressuspended and sat at 
room temperature for 5 min in order to allow complete RBCs lysis. Then, 240 l of chloroform were 
added for 1 ml of Tryzol LS added. Samples were shaken vigorously by vortex and incubated at room 
temperature for 5 min. Following incubation, samples were centrifuged at 12000 g for 25 min at 4°C.  
While centrifugation was running, aqueous phase collection tubes, columns and elution collection tubes 
were labelled and DNAse mix was prepared. When centrifugation was done, upper aqueous phase was 
transferred (avoiding white interphase which contains DNA) to a new labelled tube and volume was 
measured. Afterwards, 1.5x volume of 100% ethanol were added followed by pipetting up and down. 
Approximately 700 l was loaded to a labelled NZY binding column (blue ring), centrifuged at 13000 
g for 30 seconds at room temperature and flow-through was discarded. Any remaining sample was 
loaded to the column and centrifugation was repeated. Then, following the NZY kit protocol, for each 
sample DNAse mix was prepared by adding 10 l of DNAse I into 90 l of digestion buffer. 95 l of 
the DNAse mix was applied into the middle of the column and columns were incubated for 15 min at 
room temperature. Proceeding to washes, samples were washed once with 200 l of NWR1 and 
centrifuged at 11000 g for 30 seconds at room temperature. Following the first wash, samples were 
washed 3 times with 500 l of NWR2 supplemented with 100% ethanol and centrifuged at 11000 g for 
30 seconds at room temperature. Meanwhile, 50 l of RNAse free distilled water per sample were 
transferred to an Eppendorf tube and heated to 56°C, which were used for elution of RNA. Columns 
were transferred to new collection tubes and centrifuged at 13000g for 2 min at room temperature. Then, 
tubes were left open for 1 min to allow evaporation of ethanol, phenol, etc. Afterwards, columns were 
transferred to new RNAse free 1.5 ml tubes and eluted carefully by adding 50 l of pre-heated H2O to 
the middle of the column. Lids were closed and water was incubating for 2 min to allow H2O to absorb. 
Finally, samples were centrifuged at 11000 g for 1 min at room temperature, RNA concentration was 
measured in Nanodrop and stored at -80°C. 
 
3.2.12 – cDNA synthesis 
For each sample, the volume needed to have 400 ng of RNA was calculated and RNAse free H2O was 
added up to 20 l. 
cDNA mix was prepared using NZYTech reagents for a final volume of 20 l: 
 4 l 10x reaction buffer 
 2 l dNTPs NZY mix (10 mM each) 
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 2 l Random hexamer mix 50 ng/l 
 1 l NZY Ribonuclease inhibitor 
 2 l NZY reverse transcriptase 
 9 l RNAse free H2O 
20 l of mix and 20 l of RNA from each sample were pipetted in PCR tubes from Qiagen. 
Tubes were placed in a T100 Thermal Cycler from Bio-Rad and the following cDNA synthesis protocol 
was used: 
 25°C for 10 min 
 50°C for 50 min 
 85°C for 5 min 
Finally, tubes were stored at 4°C or -20°C for short or long-term storage, respectively. 
 
3.2.13 – Quantitative PCR (qPCR) 
Gene expression was measured by qPCRs using SybrGreen reagents in either 96 or 384-well plate. The 
mix’s composition was the following: 
 0.2 l reverse primer of target gene 
 0.2 l forward primer of target gene 
 5 l SybrGreen mix 
 3.6 l H2O 
Note: this is the mix for 384-well plate, for 96-well plate twice the volume of all reagents was added. 
The mix for each gene was pipetted in duplicate per sample plus one negative control with water instead 
of cDNA in a RT-PCR plate. Then, 1 l of cDNA was added directly to each well and 1 l of water was 
added to the negative control well. The plate was centrifuged at 3000 rpm for 3 min. 
Gene expression was measured in a RT-PCR ViiA 7 System or RT-PCR 7500Fast for 384 or 96-well 
plate respectively, and was normalized to the average of expression of the house-keeping genes. ∆∆Ct 
were calculated for each treatment and respective control (DFO vs. Control and Fe vs. Ascorbic) and 
gene expression was obtained by the formula 2-∆∆Ct.  
 
3.3 – Sequencing 
Prior to the sequencing itself, a quality control was performed for all samples by measuring the RNA 
integrity number (RIN) and concentration in order to assess the RNA quality and quantity. All samples 
were within suitable parameters (amount of RNA > 10 g and RIN > 6.9). Then, the whole-
transcriptome library was built using the TruSeq Stranded mRNA Library Preparation Kit. During this 
procedure, it was necessary to deplete rRNA as it represents 95-99% of total RNA, in order to allow 
sufficient sequencing-depth for mRNA. The generated DNA fragments (DNA libraries) were sequenced 
in the Illumina Hiseq 2500 platform, using 100bp paired-end sequencing reads. The raw sequence data 
underwent automatic initial treatment, namely adapters and low quality bases trimming. All these 
procedures were performed in the company STABVIDA Lda (project reference: 
NGS2016.0404.01(P)) 
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3.4 – RNA-seq bioinformatic analysis 
Note: all the code is written in Menlo font size 9. TopHat and Cufflinks package software are operated 
through the UNIX shell without graphical user interface. All the softwares are installed in IMM server 
Biocomp and were run in the server. This protocol is an adaptation of the one used in Trapnell et al. 
(Trapnell et al. 2012) 
The steps until the differential expression analysis are depicted in the Methods section, as they are a 
common part of the process of studying gene expression using RNA-seq.  
 
3.4.1 – Quality control 
All the samples’ quality was evaluated using FastQC High Throughput Sequence QC Report version 
0.11.4. 
 
 
3.4.2 – Mapping to reference genome 
The mapping of the reads from each sample to the P. falciparum 3D7 reference genome was performed 
using TopHat version 2.0.13, a software that aligns reads to the genome and discover transcript splicing 
sites. Bowtie is the short read aligner used by TopHat as the alignment “engine”. Bowtie is one of the 
most used and data efficient short read alignment software, as it uses a highly economic data structure 
called FM index to store the reference genome. This structure allows the reference genome to be 
searched in a fast and efficient way. Then, TopHat breaks up the reads Bowtie cannot align in smaller 
pieces called segments, which will be aligned to the genome independently (Trapnell et al. 2012). This 
version of TopHat uses Bowtie 2. 
Before running TopHat, it is needed to build a Bowtie index for the organism used in the RNA-seq 
experiment. In order to build the index, the reference genome was downloaded in FASTA format from 
genedb website: http://www.genedb.org/Homepage/Pfalciparum.  
 Code to create bowtie index for the P. falciparum reference genome (needs prior download of 
reference genome in FASTA format): 
bowtie2-build P.falciparum_index.fa Palciparum_index  
 Map reads for each sample to reference genome using TopHat: 
tophat /home/FM/msantos/Indexes/Pfalciparum_index /home/FM/msantos/Reads/Sample1-C1-
NGS2016040401P094_S1_L001_R1_001.fastq,/home/FM/msantos/Reads/Sample1-C1-
NGS2016040401P094_S1_L001_R2_001.fastq 
Note: the first argument is the path to the reference genome index, while the second argument is the 
path to both paired-end reads for each sample (left read and right read separated by comma, 
respectively). While the index is the same for all samples, the path to the corresponding sample should 
be changed. 
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3.4.3 – Assembling of transcripts 
Cufflinks is a software that assembles individual transcripts from RNA-seq reads that have been aligned 
to the genome. This is a crucial step for correct gene expression quantification. As samples may contain 
reads from multiple splice variants of a given gene, Cufflinks makes a parsimonious transcriptome 
assembly of the data. This means that it tries to infer the splicing structure of each gene and report the 
smaller number possible of full-length transcript fragments (called transfrags) needed to “explain” the 
splicing events present in the data (Trapnell et al. 2012). The cufflinks version used was 2.2.1. 
 Assemble transcripts for each sample: 
cufflinks /home/FM/msantos/TopHat_out/Sample_1/tophat_out/accepted_hits.bam 
Note: the only argument is the path to the file accepted_hits.bam, one of the output files from TopHat. 
This file is a list of read alignments in BAM format, a binary version of a SAM file. A SAM file (.sam) 
is a tab-delimited text file that contains sequence alignment data. These formats are described on the 
SAM Tools website: http://samtools.sourceforge.net. 
When working with several RNA-seq reads, it becomes necessary to pool and assemble all of them 
together in a comprehensive set of transcripts before starting the differential expression analysis. 
Cuffmerge is a script that makes part of Cufflinks software, and is able to merge several Cufflinks 
assemblies into a single unified transcript catalogue. Additionally, one can provide a reference GTF file 
(reference annotation, described in ensemble website: www.ensembl.org/info/website/upload/gff.html 
), and the script will use it to attach gene names and other metadata to the merged catalogue. The gtf file 
for P. falciparum was downloaded from sanger server 
ftp://ftp.sanger.ac.uk/pub/project/pathogens/gff3/CURRENT. This file was in gff3 format, so it had to 
be converted to gtf file (the one accepted by Cufflinks). 
 Convert gff3 file to gtf: 
gffread P.falciparum.gff3 –T –o P.falciparum.gtf 
Note: the –T option tells the command to convert the file to gtf format, while the –o option tells the 
command to give the name provided to the output file. 
 Create a file called assemblies.txt that lists the path to the assembly file from Cufflinks for each 
sample, as following: 
/home/FM/msantos/TopHat_out/Sample_1/transcripts.gtf 
/home/FM/msantos/TopHat_out/Sample_2/transcripts.gtf 
/home/FM/msantos/TopHat_out/Sample_3/transcripts.gtf 
/home/FM/msantos/TopHat_out/Sample_4/transcripts.gtf 
/home/FM/msantos/TopHat_out/Sample_5/transcripts.gtf 
/home/FM/msantos/TopHat_out/Sample_6/transcripts.gtf 
/home/FM/msantos/TopHat_out/Sample_7/transcripts.gtf 
/home/FM/msantos/TopHat_out/Sample_8/transcripts.gtf 
 Run Cuffmerge in all assemblies to create a single reference transcriptome annotation: 
cuffmerge –g P.falciparum.gtf –s /home/FM/msantos/Indexes/Pfalciparum_index.fa assemblies.txt 
Note: the –g option allows the user to provide the reference annotation file (in gtf format), while the –s 
option allows the user to provide the genomic DNA sequences for reference in FASTA format (same 
file as the one used by TopHat to map the reads). The final argument is the assemblies.txt file with all 
the path to all the assemblies generated by Cufflinks.   
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3.4.4 – Differential expression 
The program of the Cufflinks package used for differential expression analysis is called Cuffdiff. It is 
able to calculate the gene expression between two or more conditions and test the statistical significance 
of the differences between them. The statistical model used assumes that the number of reads that 
mapped to a gene is proportional to the expression of the same gene, with technical and biological 
variability being considered as fluctuation factors (Trapnell et al. 2012). Thus, providing biological 
replicates is essential in order to “teach” the model how the read counts vary between replicates and 
correctly estimate the significance of the changes between samples. 
 Use Cuffdiff with the merged transcriptome assembly from Cuffmerge to test the significance 
of changes in gene expression levels between conditions: 
cuffdiff –o CONTROLvsDFO –b /home/FM/msantos/Indexes/Pfalciparum_index.fa –u merged_asm/merged.gtf –L 
Control,DFO /home/FM/msantos/TopHat_out/Sample_1/tophat_out/accepted_hits.bam, 
/home/FM/msantos/TopHat_out/Sample_5/tophat_out/accepted_hits.bam 
/home/FM/msantos/TopHat_out/Sample_4/tophat_out/accepted_hits.bam, 
/home/FM/msantos/TopHat_out/Sample_8/tophat_out/accepted_hits.bam  
Note: the parameter –o sets the name of the directory in which Cuffdiff will write its output, the 
parameter –b allows the user to provide the genomic sequence the reads were mapped to, in order to 
detect bias and improve the accuracy of transcript abundance estimates. The parameter –u allows the 
user to provide the merged transcriptome assembly to more accurately weight read mappings to multiple 
locations in the genome, while the –L parameter specify a label for each sample which will be included 
in the output files. The last arguments are the bam files from TopHat for each sample, with replicates 
being separated by comma (in this case, sample 5 is a replicate of sample 1 and sample 8 is a replicate 
of sample 4).  
Cuffdiff produces several outputs, being the most important a table with the information from the 
differential expression analysis at the gene level between samples (gene_exp.diff). In this file is present 
the result of testing the differences in the summed FPKM (Fragments Per Kilobase of transcript per 
Million mapped fragments) of transcripts sharing each gene_id. The number of reads produced from a 
transcript is directly proportional to the expression of that transcript in the sample. However, longer 
transcripts will produce more sequencing reads, because cDNA fragments usually are size-selected 
during the library construction in order to optimize the output. As such, if gene A is expressed at the 
same rate as gene B but has twice the size, on average twice as many reads will be generated from gene 
A compared to gene B. In order to correctly compare the expression levels between two genes, the 
software must count the reads that mapped to each transcript and normalize the count by each 
transcript’s length. Also, as each run in the sequencing machine might produce a different number of 
reads, the counts must be normalized for the total yield of the machine. Both these normalization steps 
are incorporated in the FPKM values (Trapnell et al. 2012). 
Additionally, this file has several information from each transcript, like the gene id and the genomic 
coordinates, but the most important columns are the FPKM in each sample tested, the 
log2fold(FPKM_1/FPKM_2) which represents the log2(fold change) and the p-value.  
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3.5.5 – Downstream analysis 
To visualize sample similarities on a transcriptome-wide scale, we first constructed a distance matrix of 
expression profiles as follows (adapted from (Broadbent et al. 2015)): the FPKM values were 
transformed as log2(FPKM+1) and the Pearson correlation () matrix between sample expression 
profiles was computed using the R function cor(data, method = ‘pearson’) where data is a table with the 
FPKM values from each gene in each sample. Then, this matrix was transformed as (1-)/2 and MDS 
(Multidimensional scaling) was performed using the R function cmdscale(matrix_pearson) where 
pearson_matrix is the matrix from the command cor after transformation. In order to visualize the plot, 
we plotted each dimension using the R function plot. 
To visualize the expression of each transcript across samples and cluster the samples based on these 
values, we generated a heatmap using the R function heatmap.2 from the gplots package. The venn 
diagrams were done in R using the function draw.pairwise.venn from the VennDiagram package. 
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4 – Results 
 
4.1 – BLASTing: in search for putative iron-responsive genes 
The first step of the project was to perform a deep search in the literature in order to identify candidate 
genes whose expression levels might be affected by fluctuations in iron levels. These candidates were 
chosen from model organisms, namely yeast and mammalian cells (human). As described in the 
Introduction, iron metabolism and regulation is well studied in these organisms and here we aimed to 
investigate if genes that are described to alter their expression in different iron conditions are also iron-
responsive genes in Plasmodium. To that end, protein BLAST searches were performed with the 
objective of finding homologues in P. falciparum (see Methods). For the cases where a potential 
homologue was identified, a multiple alignment using Clustal Omega was performed to investigate the 
overall sequence similarity and the regions of the protein that shared the highest sequence identity (see 
Methods). The E-value obtained through BLAST search is a parameter that describes the number of hits 
one can “expect” to see by chance when searching a database of a particular size. E-value of 1 assigned 
to a hit signifies that in a database of the current size one might find another sequence with the same 
score by chance. Therefore, a BLAST result is more reliable when its E-value is closer to zero.  
While it was not possible to identify any P. falciparum homologues of the main iron sensors of S. 
cerevisiae, Aft1/2 or Yap5 transcription factors, several genes were identified that shared low sequence 
identity with the two mRNA-binding proteins Cth1 and Cth2. As described in the Introduction, these 
proteins are expressed by the action of the transcription factors Aft1/2 in conditions of low iron, and act 
by binding to AREs in the target mRNAs and transport them to the cytosol where they will be degraded. 
While using Cth1 as a query we found 3 blast hits, and Cth2 only one. For Cth1, the candidate chosen 
to test further was the one that exhibited higher sequence identity (42%) with a query coverage, i.e, 
percentage of the query sequence that overlaps the subject sequence, of 19%. For Cth2, the only 
candidate had 43% of sequence identity. Two issues with this candidate is that the E-value was quite 
high (1.1) and the query coverage was low (11%). The low query coverage of both these candidates 
might be explained by the fact that both P. falciparum Cth1and Cth2 have a longer amino acid sequence 
compared to the yeast homologue sequences (843 and 1722 compared to 325 and 285, respectively), 
and that the regions sharing sequence similarity are the ones involved in mRNA-binding, with the rest 
of the sequence being significantly different. 
S. cerevisiae Grx4, the monothiol glutaredoxin (UniProt ID P32642) involved in the formation of Fe-S 
cluster and transport of the iron signal to the nucleus in yeast (see Introduction) did not have a hit in P. 
falciparum. As we consider that this protein has an important role in iron metabolism, we performed a 
BLAST search using the Schizosaccharomyces pombe (fission yeast) Grx4 (UniProt ID O74790) and 
were able to find a hit, PF3D7_0606900, a gene currently annotated in PlasmoDB (Plasmodium 
Genomics Resource) as a glutaredoxin-like protein (GLP2). S. pombe is widely used to study iron 
metabolism and regulation, and its Grx4 has a similar role as the one from S. cerevisiae, being an 
inhibitory partner of Fep1 under iron depletion conditions, a transcription factor regulating the 
transcription of several genes involved in iron metabolism (Labbé et al. 2013).  
The ER-bound protein Tyw1, which is upregulated upon Yap5 activation in iron excess condition, 
detoxifies iron excess by binding it as Fe-S clusters. BLAST search identified one putative homologue 
for Tyw1 in P. falciparum. Also, homologues were identified for Tsa1 and Prx1, a molecular chaperone 
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that might be important for inhibition of Aft1/2 and a mitochondrial peroxiredoxin that might be 
involved in low iron signaling, respectively (Outten & Albetel 2013). Finally, Mrs3 a mitochondrial 
iron transporter whose deletion affects the activity of the vacuolar iron transporter Ccc1 in yeast (Li et 
al. 2010), had two putative homologues in P. falciparum, which were named here as MrsA and MrsB. 
Our analyses also included homologues of ferrochelatase, the last enzyme of haem biosynthesis pathway 
located in the mitochondria (Nagaraj et al. 2009), and VIT, the homologue of yeast CCC1 (see 
Introduction, Yeast iron sensing and regulation). Several homologues of human transporters were also 
tested, namely DMT, ZIP1, ZIP2 (ZIPCO), ZIP3 and CuTP, a copper transporter (Kenthirapalan et al. 
2014). In addition, a homologue of mammalian IRP was also included in the analyses, (Loyevsky et al. 
2003). Table 4.1 shows all the genes which expression was tested in response to iron, including the 
house-keeping genes used for normalization. 
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Table 4.1 – Candidate genes for which expression levels were tested after the iron treatments: the first column describes 
the gene’s short name, the second shows PlasmoDB ID, the third and fourth columns show the BLAST E-value and the 
percentage of sequence identity determined using Clustal Omega, respectively, and in the last the function (putative if it is not 
known in Plasmodium). Notes: *BLAST search against human homologue **last four genes are the house-keeping genes used 
to normalize the gene expression levels. 
Candidates  
P. falciparum 
ID 
BLAST E-
value 
% id 
(clustal) 
Function (some of them only predicted 
by homology) 
Cth1 PF3D7_0906600 0.004 25,3 mRNA-binding protein 
Cth2 PF3D7_1134600 1.3 23,16 mRNA-binding protein 
Grx4 PF3D7_0606900 3E-22 27,4 Monothiol glutaredoxin 
Tyw1 PF3D7_0524900 1E-127 35 Fe-S cluster binding protein 
Tsa1 PF3D7_1438900 9E-50 43,01 Molecular chaperone 
Prx1 PF3D7_0802200 1E-49 41,98 Mitochondrial peroxiredoxin 
MrsA PF3D7_1241600  1E-15 28,4 Mitochondrial iron transporter 
MrsB PF3D7_0905200 4E-12 31,14 Mitochondrial iron transporter 
Ferrochelatase PF3D7_1364900 3E-15 22,78 
Last enzyme of haem biosynthesis 
pathway 
VIT PF3D7_1223700 6E-8 21,71 Vacuolar Iron Transporter 
DMT* PF3D7_0523800 1E-39 26,92 Divalent Metal Transporter 
ZIP1* PF3D7_0609100 2E-11 24,23 Zn2+ or Fe2+ permease 
ZIP2* PF3D7_1022300 0,009 18,89 ZIP domain-containing protein (ZIPCO) 
ZIP3* PF3D7_0715900 9E-25 30,52 Zinc transporter putative 
CuTP* PF3D7_0904900 6E-35 23,3 Copper transporter 
IRP* PF3D7_1342100 0 53,74 Iron-regulatory protein 
18S rRNA** PF3D7_1148600 - - House keeping 
Serine tRNA ligase** PF3D7_0717700 - - House keeping 
Inositol 5-phosphatase** PF3D7_0802500 - - House keeping 
Adenylosuccinate lyase 
(ASL)** PF3D7_0206700 - - House keeping 
 
4.1.1 – Iron treatments are changing iron levels in the iRBCs 
After having the candidate genes chosen, we developed a strategy to test if their expression is altered in 
response to iron. For that, we simulated artificial iron depletion and iron excess conditions in blood stage 
P. falciparum parasites in vitro (see Methods) to obtain samples for RNA extraction and gene expression 
analysis by qPCR. 
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Before starting testing our candidate genes 
expression in response to iron, we asked whether 
the treatments were changing the iron levels of the 
parasite environment. To assess that, we 
measured the labile iron pool of infected RBCs 
using PhenGreen (see Methods), a fluorescent 
dye whose fluorescence is quenched by iron, 
therefore its fluorescence signal is inversely 
correlated with iron concentration (more iron 
results in lower fluorescence and vice-versa). As 
the fluorescence signal of the controls was 
different between experiments, we normalized all 
the fluorescence values to the controls (which 
were also normalized to the mean of the controls) 
before pooling the data from independent 
experiments.  
Figure 4.1 clearly shows the effect of the 
treatments on the labile iron pool of the infected 
RBCs. After 6 hours, PhenGreen fluorescence of 
infected RBCs in the DFO condition is significantly higher compared to the control condition, meaning 
that DFO is efficiently chelating iron. This effect is maintained after 24-hour treatment. In the opposite 
scenario, after 6 hours of FeSO4 treatment, the PhenGreen fluorescence is lower compared to its control 
condition (ascorbic acid treatment), showing that with addition of FeSO4 to the medium in the presence 
of ascorbic acid, the labile iron pool of infected RBCs is higher. However, this effect seems to be lost 
after 24-hours of FeSO4 treatment, meaning that the parasite might be metabolizing the iron excess or 
transporting it outside the infected RBCs. It is curious to note that in the AA condition the fluorescence 
is slightly decreased compared to the control condition, which indicates that AA might be quenching 
the fluorescence by some iron-independent mechanism. This must be taken into account, as ascorbic 
acid is also added to the Fe condition in order to keep it in the ferrous form (the iron form permeable to 
biological membranes, see Methods). Nevertheless, the difference between Fe + AA condition and AA 
alone after 6 hours is significant. 
These results validate our experimental approach to introduce changes in iron concentration in P. 
falciparum infected RBCs. While chelation of iron with DFO is appropriate for both short and long term 
treatments, by addition of FeSO4 labile iron pool in iRBCs is changed only transiently, suitable for short-
term treatments. Therefore, further experiments were set up with 6h treatments. 
Figure 4.1 – PhenGreen fluorescence of iRBCs after 6h (left) 
and after 24h (right) treatments: C (Control), DFO 
(deferoxamine 20M), AA (Ascorbic Acid 200M), Fe (FeSO4 
200M + AA 200M); statistical test: unpaired, two-tailed t-test. 
Shown are mean + SEM of 4 replicates from 2 independent 
experiments. * p < 0,05; ** p < 0,01; *** p < 0,001. 
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4.1.2 – Iron treatments are not affecting parasites’ viability 
Next, we asked if the treatments were affecting the parasites viability, i.e, if the parasites were being 
killed or delayed in their development. This is important given that we aimed to identify iron-dependent 
changes in gene expression, and to avoid those that are merely due to the delayed or halted parasite 
development. To address this question, we set up the treatments as previously and after 6 hours the 
medium was replaced with standard culture medium without any treatment and the parasites were 
allowed to grow for additional 24 hours. Smears were made at the time of replacing medium and after 
24 hours in fresh medium (Fig. 4.2).  
 
Figure 4.2 – Blood smears of infected RBCs in the different conditions; top row, smears after 6 hours in the treatments, 
bottom row, smears after 24 hours in replaced medium without any treatment. 
As illustrated in figure 4.2, after 6 hours most of the parasites were in the trophozoite stage and we could 
not observe any difference in the appearance of parasites under treatment compared to control parasites. 
After 24 hours in fresh medium without the treatments, it seems that the parasites were able to complete 
the life cycle, fully developing to new merozoites capable of invading new RBCs, as all the conditions 
had a similar number and developmental stage of ring-stage parasites (parasitemia of 11.4%, 11.5%, 
9.3% and 11.4% for Control, DFO, AA and Fe + AA respectively). 
This result further supports our system as a valid one to study how the parasites respond to iron without 
compromising their survival. The next obvious question is if the parasites are in fact responding to these 
iron perturbations by changing their transcriptome and if we can identify iron-responsive genes. 
 
4.1.3 – Iron treatments are affecting the expression levels of some candidate genes 
After confirming that our system was affecting iron levels without compromising parasite’s 
development or survival, we set up treatments in sorbitol-synchronized parasites in the old-ring/young 
trophozoite stage, and extracted the RNA after 6 hours in order to quantify gene expression of our 
candidates identified in Table 4.1 by qPCR (see Methods). We chose this “window of time” of the life 
cycle as it is the most metabolically active one and we considered that it might exhibit the higher iron 
responsiveness. We also analysed gene expression in other time-points, namely after 2, 24 and 48 hours 
After 6h 
After 24h 
DFO AA Fe + AA Control 
   27 
of treatment but we encountered some issues regarding them: as the results from the PhenGreen assay 
showed, the FeSO4 treatment is not inducing changes in the labile iron pool after 24 hours, which we 
also assume to be true for the 48-hour treatment. On the other hand, the DFO effect seemed to be stronger 
after 24 hours when compared to 6 hours, which remains to be tested for 48-hour treatment. Regarding 
the 2 hour time-point, there are studies testing transcriptional responses to compounds showing that after 
2 hours one might only detect a “general stress response” instead of a specific response to the treatment 
(Gupta et al. 2016). For these reasons, only results from 6h treatments will be discussed here. 
Relative gene expression 
of our candidates 
determined by qPCR 
(see Methods for 
calculation and 
normalization) after 6 
hours in the different iron 
conditions is illustrated 
in Figure 4.3. We 
observed mild changes in 
expression of this 
selection of genes, with 
the highest fold-change 
around 1.5 and the lowest 
around 0.5 (dashed line 
was placed in value 1, i.e, 
no changes in gene expression). Also, we have observed great variability in expression of some genes 
between experiments. The lack of reproducibility may be due to the biological variability between 
experiments, with some genes showing greater changes in one experiment and subtler changes in 
another, while others were even behaving in opposite directions between experiments. This fact could 
be explained by the possibility that our candidates do not have the same role as their homologues in 
other species, meaning they are not responding to changes in iron levels. If this scenario is true, changes 
in gene expression of some of the candidates are due to stochasticity. 
However, several genes showed alterations in expression which were, even though small, reproducible 
between experiments and statistically significant: starting with DMT, whose expression increases in 
response to DFO (one sample t-test, p-value = 0.0135). This can point to the role of DMT in re-
stablishing normal iron levels inside cells, by transporting it into the parasite cytosol. Ferrochelatase, 
the last enzyme of the haem biosynthesis pathway, was also significantly down-regulated in DFO 
condition (one sample t-test, p-value = 0.0184). This result indicates that in iron depletion condition the 
parasite might be shutting down haem synthesis, one pathway highly dependent of iron. The 
mitochondrial iron transporter MrsB was also significantly down-regulated in DFO condition (one 
sample t-test, p-value = 0.0184), indicating reduced iron transport into the mitochondria, as there is less 
iron available. It is interesting to observe that CuTP, the copper transporter, was significantly up-
regulated in the DFO condition (one sample t-test, p-value = 0.0436). This result suggests a potential 
capacity of this transporter to bind and transport iron, in order to re-establish the normal iron levels 
inside the cell, or the possibility that some of the copper may be also chelated by DFO. The putative 
mRNA-binding protein Cth2 was the only one whose gene expression changed in response to Fe 
significantly (one sample t-test, p-value = 0.0435). Having this result in mind, this gene persists as an 
interesting target to pursue and unveil its expected mechanism of post-transcription regulation in 
response to iron levels in the parasite environment.  
 * 
Figure 4.3 – Relative gene expression in P. falciparum after 6 hours with FeSO4 and 
DFO compared to their corresponding control parasites Shown results are mean + SEM 
of 3 independent experiments. One sample t test: * p < 0,005 
     * 
   * 
  * 
 
    * 
      * 
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4.2 – RNA-seq: genome-wide quest for iron-responsive mechanisms 
Having the previous results in 
mind, we decided to advance to 
the RNA-seq experiment with the 
objective of genome-wide 
identification of genes 
differentially expressed between 
the iron conditions tested, which 
we hypothesized to be involved in 
iron sensing or iron-regulatory 
processes. The samples for RNA-
seq were prepared as described in 
the Methods section: culture of 
sorbitol-synchronized old 
rings/young trophozoites was 
split into four parallel cultures 
under the following conditions: 1- 
Control (regular growth 
medium); 2- medium with the 
addition of 200 M of FeSO4 and 
200 M ascorbic acid; 3 – medium with the addition of 200 M ascorbic acid and 4 – medium with the 
addition of 20 M of the iron chelator deferroxamine (DFO). 6 hours after the start of the treatments, 
total RNA was extracted to be sent for sequencing, so that at the time of extraction our parasites were 
all at the trophozoite (24-30 hours post-invasion) (Fig. 4.4). In order to have valid biological replicates, 
parasites in normal culture conditions were let to complete one cycle (approximately 48 hours) and 
treatments were repeated. One round of sorbitol was performed in order to keep parasites synchronized. 
After the RNA extraction was completed for all eight samples, the quantity and quality of RNA was 
checked. We were able to obtain high amounts of RNA (approximately 20 g with concentrations above 
230 ng/l for all samples) with good integrity as confirmed by agarose gel and purity as confirmed by 
Nanodrop measurements (Figure 4.5 and Table 4.2, respectively). The quality of the samples was further 
confirmed by the company (see Methods).  
Figure 4.4 – Experimental workflow: sorbitol-synchronised P. falciparum 
blood stage parasites were placed in each condition, RNA was extracted after 6 
hours and sent for sequencing in order to identify differentially expressed genes.  
 
Sample 
RNA 
concentration 
(ng/µl) 
260/280 260/230 
Total RNA 
(µg) 
Sample 1 - C1 244.59 2.31 2.50 22.013 
Sample 2 - Fe1 308.46 2.17 2.28 27.761 
Sample 3 - Aa1 439.01 2.25 2.46 39.51 
Sample 4 - DFO1 231.16 2.32 2.72 20.804 
Sample 5 - C2 233.9 2.45 2.68 21.051 
Sample 6 - Fe2 271.3 2.11 2.03 24.417 
Sample 7 - Aa2 242.8 2.45 2.65 21.852 
Sample 8 - DFO2 298.1 2.44 2.70 26.829 
Table 4.2 – RNA concentration and ratios measured using Nanodrop and amount of RNA for each sample. 
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RNA was sequenced at the STABVIDA facilities through Next-generation Sequencing of the cDNA 
molecules generated from each sample and raw sequence data of the transcriptome from the total RNA 
were obtained as FASTQ files. Most samples generated from 25 274 096 to 48 249 776, which is in 
accordance with the expected output (around 20 000 000 sequence reads). However, the sample 1 
(Control 1) had an output below this expectation (14 643 906), which might affect the bioinformatics 
analyses (see Supplementary information, Table S1). The quality of the data produced was determined 
using the FastQC tool (see Methods). All the samples had a Phred quality score at each cycle (position 
in read) indicative of good quality (above 28). The Phred quality score (Q) is a measure of the quality 
of identification of the nucleobases generated by automated DNA sequencing, which is inversely 
logarithmically related to the base calling error probabilities (P): Q = -10 log10P. For example, if a base 
has a Phred score of 10, the probability that it was incorrectly called is 10%. If the score is 20 the 
probability is 1%, 30 is 0.1%, and so on (Ewing et al. 1998). An example of the plot generated by 
FastQC tool for Sample 4 - DFO1 and Sample 7 – AA2 can be found in supplementary information 
(Figure S1). 
After mapping the reads to the reference P. falciparum 3D7 genome using TopHat (see Methods), we 
observed that for most samples between 92 and 96% of the reads mapped to the reference genome, 
except for sample 1 (Control 1) where 87.3% of the reads mapped to the reference genome. This might 
be due to the lower number of sequence reads originated from this sample. 
 
4.2.1 – A replication issue: when the highly regulated P. falciparum blood stage transcriptome becomes 
a problem 
After having the reads from each sample mapped to the reference genome, the transcripts assembled 
and a merged single reference transcriptome generated from all samples using Cufflinks and Cuffmerge, 
respectively (see Methods), we proceeded to the differential expression analysis. Since two independent 
biological replicates were sequenced for each condition, replicates were initially pooled for the 
differential expression analysis, as it is normally performed in similar studies (Broadbent et al. 2015). 
However, after performing the differential expression analysis comparing pooled replicates of Control 
vs. DFO and FeSO4 vs. Ascorbic acid conditions, none of the genes was significantly up or down 
regulated within each pair of conditions. More specifically, for genes which were at least 2-fold up or 
down-regulated, obtained false discovery rate values (FDR) were not supporting statistical significance. 
C1 Aa1Fe1 DFO1
28S rRNA
18S rRNA
C2 Aa2Fe2 DFO2
28S rRNA
18S rRNA
Figure 4.5 - Agarose gels with RNA samples sent for sequencing: left, replicate 1; right, replicate 2, C – Control, Fe – 
FeSO4 + Ascorbic acid; Aa – Ascorbic acid; DFO – deferoxamine. The bands corresponding to 28S and 18S rRNA are 
highlighted to confirm RNA integrity. 
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This result was unexpected given the observed levels of fold-change for the most highly differentially 
expressed genes (log2fold change 4.461 and -2.833 for FeSO4 vs. Ascorbic acid and 7.20 and -7.51 for 
Control vs. DFO) and thus we hypothesized that the variability between the biological replicates could 
be the reason for the outcome of the initial analysis. The highly periodic pattern of the blood stage 
transcriptome means that small shift in the developmental stage of the parasites leads to great difference 
in gene expression values, as discussed in the Introduction (Lemieux et al. 2009). Therefore, one 
possibility was that between the two days of the experiments the parasites were not exactly in the same 
developmental stage, which means that they varied significantly in terms of gene expression and that 
considered biological replicates were not true replicates. This would mean that the gene expression 
changes due to the different development stages between the replicates could be “masking” the changes 
due to the iron treatments. 
To test this hypothesis, we performed the differential expression analysis considering the day of the 
experiment as the variable introducing changes in gene expression levels, meaning the four conditions 
set up on the first day were replicates of each other, and the same for the conditions set up on the second 
day. We are sure that the parasites within each day are exactly in the same developmental stage, as each 
treatment was set up separately from a single culture of sorbitol-synchronized parasites. Also, by pooling 
the four experiments of each day as replicates we are increasing the statistical power of the analysis, so 
it would be possible to identify significant differentially expressed genes.  
The results obtained by this analysis confirmed our hypothesis, as out of the 5853 genes 300 were 
significantly up-regulated (log2 fold change > 1 and p-value = 5,00E-05) and 130 were significantly 
down-regulated (log2 fold change < -1.9 and p-value = 5,00E-05) in the samples from second day 
compared to the first. The first evidence indicating that our parasites were in a later developmental stage 
on the second day of experiment comparing to the first was the fact that seven SERA (Serine Repeat 
Antigen) genes were up-regulated on day 2, and it is already described that these subset of genes is up-
regulated later in the blood stage (Miller et al. 2002). To address this, we compared our data with the 
RNA-seq dataset across the blood stage from Otto et. al (Otto et al. 2010) available on PlasmoDB (Fig. 
4.6). In their dataset, they identified 1140 genes up-regulated (fold difference > 2) in the 32-hour time-
point (corresponding to old trophozoite) compared to the 24 hour time-point (corresponding to young 
trophozoite). In our 
dataset, of the 300 
identified as being 
upregulated on the 
second day compared to 
the first day, 187 (62%) 
overlapped with data 
from Otto et. al, which 
further strengthens the 
hypothesis that our 
parasites were in a later 
developmental stage in 
the second day 
compared to the first 
(Figure 4.6 left). In 
addition, in their dataset 
they identified 696 genes 
down-regulated (fold 
difference > 2) in the 32 
Figure 4.6 –Comparison of genes differentially expressed between the 2 experiments 
with the data published by Otto et. al confirms the shift in parasite development between 
experimental days: left: of the 300 up-regulated on the second day, 187 overlapped with the 
data published; right: of the 130 down-regulated on the second day, 59 overlapped with the 
data published. 
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hour time-point compared to the 24 hour time-point and in our dataset, of the 130 genes identified as 
being downregulated on the second day compared to the first 59 (45%) overlapped with data from Otto 
et. al, validating our hypothesis (Figure 4.6 right).  
 
4.2.2 – The clock-like pattern of gene expression 
As we consider that the replication issue we faced is of major importance to further explain all our 
results, we decided to perform a Multidimensional scaling (MDS) to assess stage similarities on a 
transcriptome-wide scale (see Methods). This approach was used by Broadbent et al., in their work 
where they performed RNA-seq across the blood stage in order to identify developmentally regulated 
lnc-RNA (long non-coding RNAs) (Broadbent et al. 2015). By performing this analysis, they were able 
to show that their samples were placed around a circle, progressing through the 48 hours P. falciparum 
blood stage according to their time and morphology. We downloaded their gene expression results and 
performed the same analysis, and were able to obtain the same clock-like pattern (Figure 4.7 - A). Then, 
the analysis was repeated together with our data, in order to identify where our samples would fall in 
the “blood-stage transcriptomic clock” (Figure 4.7 - B).  
 
By looking to Figure 4.7-B it is possible to see that the clock pattern is preserved, and that our samples 
from each day group together with each other. However, the points representing our samples do not fall 
exactly in the circle, which is expected as our samples were not treated exactly in the same way as the 
ones from the paper (RNA extraction and the library preparation protocol were not the same, for 
example). Despite that, a clear shift is present, with samples from day 1 appearing more to the left 
(younger in development) compared to samples from day 2. This result confirms the assumption that 
Figure 4.7 – Multidimensional scaling (MDS) confirms the P. falciparum transcriptome pattern across the blood stage: 
A - analysis performed with the data from Broadbent et. al; B – same analysis with addition of our data. The colour scheme is 
the following: red corresponds to ring stage, blue to trophozoite and green to schizont, while our data points are coloured in 
black.   
   32 
parasites were in different development stages between the two days of the experiments, suggesting that 
they should not be analysed as biological replicates. 
 
4.2.3 – Pairwise comparison: finding common patterns between treatments and experiments 
After our analysis showed that the data from the two days of experiments should not be considered as 
replicates, we decided to perform a pairwise comparison between each treatment and its corresponding 
control (DFO vs. Control and Fe vs. Ascorbic Acid) separately for each experimental day. We aimed to 
identify genes which responded in an opposite direction between the iron excess and iron depletion 
conditions in the same day of the experiment. Also, genes behaving in the same way between both days 
of experiments are more likely to be truly involved in iron-related functions irrespective of the 
developmental stage of the parasites.   
Figure 4.8 represents a clustered heatmap 
based on the expression levels of each 
transcript (see Methods). Samples are 
clustered based on the mean of log2(FPKM) 
of all genes. It is evident that sample 1 (C1) 
is clearly unrelated from all the other, which 
might also be a factor affecting the analysis 
and further supporting pairwise comparisons 
instead of analysis with pooled “replicates”. 
This difference in C1 sample is likely an 
artefact due to the lower number of reads 
generated from this sample. To avoid 
artefacts in expression changes which are 
probably result of technical problems during 
the library preparation or sequencing 
reaction, we decided to not consider sample 
1 (C1) as a valid one, and therefore 
comparison between Sample 1 (C1) and 
Sample 4 (DFO1) will not be presented here. 
The cluster of the genes followed the same 
rule as the cluster of the samples, i.e., the 
mean of log2(FPKM+1). 
Since pairwise comparisons are made 
without replicates, the p-values obtained by 
the analysis cannot be considered. In order to 
identify genes with changes in gene expression between the two iron conditions, we made a cut-off at 
the log2(fold-change) as follow: a gene is considered up-regulated if the log2(fold change) is higher than 
1 (fold change> 2) and is considered down-regulated if the log2(fold change) is lower than -1 (fold 
change<0.5).  
Additionally, the FPKM value from each gene was taken into account. Genes for which the FPKM was 
low to a point that the software was not able to compare the gene expression between the samples 
(usually <0.1) were not considered for the analysis. It is important to note that in general our results 
resemble the studies addressing transcriptomic changes in iron deprivation conditions in yeast (see 
Figure 4.8 - Clustered heatmap shows the visual representation 
of the samples’ comparison based on the expression values of 
each transcript as log2(FPKM+1): the four samples from day 2 
cluster together and completely apart of samples from day 1. Cluster 
of genes is based on the mean of log2(FPKM+1) for each gene. 
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Introduction), with around 3% of the genes having changes in their expression between different iron 
conditions. 
From the experimental day 1 samples, as explained previously, we only analysed the results from the 
comparison between ascorbic acid (AA) and FeSO4 (Fe) conditions. Of the 5434 genes, after removing 
genes which did not have a FPKM value > 0 in both samples, 109 genes were up-regulated and 81 were 
down-regulated according to our cut-off settings. The gene ontology enrichment was performed but was 
found not informative as of all differentially expressed genes, 70 were annotated with “unknown 
function”. The remaining genes were carefully investigated in order to identify those which might be 
iron-related: an ATP synthase mitochondrial F1 complex assembly factor 1 (ATP11, PF3D7_1209800) 
was up-regulated with Fe treatment (log2 fold change = 1.35). This result is potentially interesting, as it 
might indicate that the parasite is reprogramming its metabolism in response to the increase in the iron 
concentration. One gene encoding a protein with a zinc finger domain (ZF1, PF3D7_1407700) was also 
in the group of genes up-regulated with the Fe treatment, with a log2(fold change) of 1.16. These motifs 
are usually present in transcription factors, and as such this gene may have a role in transcriptional 
regulation of genes involved in iron metabolism (as it happens in yeast). It is also interesting that 
ubiquitin-activating enzyme E1 (UbE1, PF3D7_1350400) was up-regulated with the Fe treatments (log2 
fold change = 1.57). This may indicate the existence of iron-responsive proteasomal degradation of 
proteins involved in iron metabolism is iron-responsive, as observed in the mammalian cells (Thompson 
& Bruick 2012), which could be further tested through proteomic approaches. Interestingly, a putative 
magnesium transporter (MgT1, PF3D7_0827700) was also identified as up-regulated with Fe (log2fold 
= 2.5), which might suggest promiscuity of this transporter for its substrate. 
Analyses of the samples collected on the second experimental day, included both DFO and Fe treatment 
conditions. For DFO vs. Control pairwise comparison, out of the 5424 genes with a FPKM value above 
> 0 in both samples, 119 were up-regulated and 61 were down-regulated with the DFO treatment. Again, 
the gene ontology enrichment lacked meaningful and informative GO terms due to the high number of 
genes annotated as “unknown function” (64 out of the all differentially expressed). We investigated 
carefully the remaining differentially expressed genes in order to find potential iron-related functions. 
PUF2 (PF3D7_0417100), an mRNA-binding protein was up-regulated with the DFO treatment (log2fold 
change = 1.09). This might indicate a mechanism of post-transcriptional regulation in response to iron 
deprivation conditions, as the one present in yeast and mammalian cells using Cth1/Cth2 and IRP, 
respectively. Another interesting result was upregulation (log2fold change = 1.06) of the RNA of 
unknown function, RUF6-2 (PF3D7_0711800). Although the FPKM values were low in both samples, 
we decided to keep it as a candidate to pursue, as non-coding RNAs which are lowly expressed might 
have important biological functions. A SET domain protein (SET4, PF3D7_0910000) was also found 
up-regulated with the DFO treatment (log2fold change = 2.1). This protein has histone-lysine N-
methyltransferase activity, and it might be involved in epigenetic mechanisms of gene regulation, by 
introducing methyl groups in the histones of the chromatin. This would be the first description of the 
involvement of epigenetic marks in the regulation of iron-related genes in Plasmodium. Importantly, the 
ubiquitin-activating enzyme E1 (UbE1, PF3D7_1350400) described above to be up-regulated with Fe 
treatment, was found here down-regulated (log2fold change = -1.02). 
Pairwise comparison was also performed between ascorbic acid (Aa) and FeSO4 (Fe) samples collected 
on the second experimental day: of the 5401 genes with FPKM > 0 in both samples, 89 were up and 111 
were down-regulated with the Fe treatment. In this comparison we were able to find several genes 
potentially involved in iron-related processes: starting with the ABC transporter F family member 1 
(ABCF1, PF3D7_0813700) which was up-regulated (log2fold change = 2.2) in the Fe condition. This  
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family of transporters have ATPase activity and are involved in drug resistance in Plasmodium, as they 
transport a wide range of structurally and functionally diverse amphipathic compounds (Koenderink et 
al. 2010). The fact that this gene is up-regulated in an iron excess conditions indicates a possible 
involvement in iron regulation. Also found up-regulated in the Fe condition (log2fold change = 1.52) 
was PF3D7_1467000, a gene assigned as a membrane protein with unknown function, but with assigned 
GO-terms “magnesium ion transmembrane transporter activity” and “RNA-binding” (referred as 
MgT2). A folate transporter (FT1, PF3D7_0828600) was down-regulated (log2fold change = -2.47) in 
the Fe condition. As there are some evidences that haem transporters and folate transporters might be 
related (Andrews et al. 2007), we found this observation interesting, as the parasite might be blocking 
the haem transport whit the increase of iron concentration. Another gene annotated as unknown function 
(DBP, PF3D7_1231300) was up-regulated (log2fold change = 1.08) and had the following GO terms: 
“regulation of transcription, DNA-dependent”, “DNA-binding” and “zinc ion binding’, which clearly 
places it has a potential transcription factor. Another transcription factor, belonging to the family of 
transcription factors with AP2 domains (ApiAP2_1, PF3D7_0404100) was down-regulated in the Fe 
condition (log2fold change = -1.17). AP2 family of transcription factors is considered as a major 
transcriptional regulation in Plasmodium, and the AP2 domains they possess are homologous to the AP2 
family of transcription regulators in plants, playing important roles in development and environmental 
stress response pathways (De Silva et al. 2008). It is tempting therefore to propose this specific AP2 
proteins as a transcriptional regulator of genes involved in iron metabolism. Another protein annotated 
as “unknown function” which was up-regulated (log2fold change = 1.32) had interesting GO terms 
associated, such as “tetrapyrrole biosynthetic process” and “uroporphyrogen-III synthase activity” 
(TePy, PF3D7_1247600). These GO terms are strong indicators that this protein is involved in haem 
biosynthesis, which is also strongly related to the iron metabolism. 
 
The group of differentially expressed genes upon Fe treatment on day 2, includes genes that are 
expressed in opposite directions compared to the DFO treatment. This includes RUF6-2, the RNA of 
unknown function which was up-regulated with DFO. This gene was down-regulated (log2fold change 
= -1.31) with the Fe condition. The SET4 protein up-regulated with the DFO treatment was down-
regulated (log2fold change = -1.11) with the Fe, raising the probability of being involved in an iron-
related mechanism. Table 4.3 summarizes the number of genes differentially expressed between each 
conditions on both experiments, as well as the number of genes annotated as “unknown function” 
(Control vs. DFO from day 1 are excluded for the reasons already discussed). 
As explained previously, due to the problem of developmental stage difference between the 2 
experiments, we considered the pairwise gene expression comparison as the most valid approach. 
Nevertheless, pooled analysis of ‘replicate’ experiments may identify genes which are differentially 
expressed irrespectively of the developmental stage of the parasites. Thus, we performed this analysis 
for the Ascorbic acid and FeSO4 treated samples (DFO-treated samples could not be analysed in this 
way given the technical problems with control 1 sample). Using this analysis, there were some 
Table 4.3 – Summary of the number of genes differentially expressed in the experimental conditions (up and down-
regulated) as well as the number of genes annotated as “unknown function” within the differentially expressed genes 
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interesting results: expression of two ApiAP2 transcription factors was changed in opposite directions, 
as one (ApiAP2_2, PF3D7_1317200) was up-regulated and the other (ApiAP2_3, PF3D7_1429200) 
was down-regulated (log2fold change = 1.48 and -2.35, respectively). Surprisingly, the latter had the 
sequence to which the former specifically binds, pointing to activation of a transcriptional cascade in 
response to changes in the iron levels. Finally, PF3D7_0519300 a cytochrome c oxidase assembly 
protein (haem A: farnesyltransferase) was up-regulated (log2fold = 1.5), again showing the possibility 
that the parasite is regulating its haem biosynthesis pathway in response to iron perturbations. 
Table 4.4 – Genes differentially expressed in the different iron conditions: genes are arranged in categories and the fold-
changes determined by qPCR and RNA-seq are displayed. The colour code gradient is the following: red up-regulated, green 
down-regulated, white no change in gene expression. Note that the fold changes determined by RNA-seq are much higher and 
lower for up and down-regulated genes, respectively. Genes that were determined as up or down-regulated with only one of 
the treatments only have that value of fold-change and the respective qPCR. 
Category Name qPCR fold change (Fe/DFO) RNA-seq fold change (Fe/DFO) 
Transcriptional 
regulation 
ZF1 1,57 - 2,23 - 
ApiAP2_1 0,78 - 0,44 - 
ApiAP2_2 0,85 - 2,79 - 
ApiAP2_3 0,98 - 0,20 - 
DBP 1,02 - 2,11 - 
Non-
transcriptional 
regulation 
PUF2 - 1,17 - 2,13 
RUF6-2 2,9 0,79 0,40 2,08 
SET4 1,03 1,40 0,46 4,28 
UbE1 1,51 1,19 2,96 0,49 
Metabolism 
ATP11 1,1 - 2,55 - 
ABCF1 0,85 - 4,59 - 
Transport 
MgT1 1,33 - 5,66 - 
MgT2 1,02 - 2,87 - 
 
Haem metabolism 
 
FT1 0,75 - 0,18 - 
TePy 0,7 - 2,50 - 
Farnesyltransferase 0,95 - 2,83 - 
 
Finally, to validate our RNA-seq results we designed primers to test a group of differentially expressed 
genes selected based on the level of the fold change and putative function, by qPCR analysis. The 
directions of gene expression changes detected by qPCR seemed to follow the trend of RNA-seq results, 
meaning almost all genes tested were up or down-regulated both in RNA-seq and qPCR results. The 
genes whose validation by qPCR revealed opposite results were among the ones with the lowest FPKM 
values, meaning they had less sequencing reads which might compromise the mapping and consequent 
analysis. Also, the fold change values were found to be much higher or lower for up and down-regulated 
genes, respectively, in the RNA-seq results compared to the qPCR. This is often reported to occur 
because the normalization methods are different (FPKM in RNA-seq vs. relative expression comparing 
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to the house-keeping genes in qPCR) and also due to the higher sensitivity of RNA-seq to detect subtler 
changes. Also, it might be the case that the primers we designed do not allow 100% efficiency of PCR 
amplification of our target genes, which could introduce changes in the fold change values. Finally, 
prior to RNA-seq library preparation, samples were depleted for ribosomal RNA, while our qPCR was 
performed on total parasite RNA, which may also lead to differences in analysis. The information about 
the genes’ category of function and fold changes determined by qPCR and RNA-seq are displayed on 
table 4.4.  
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5 – Discussion 
 
As iron is essential for both the host and the pathogen, complex interactions develop between the two 
organisms that are in a battle for this micronutrient. Consequently, understanding this host-pathogen 
interaction may become a herculean task. Both the replication of the parasites and the immunity of the 
host are affected by iron levels (see Introduction). Therefore, many studies investigated the influence of 
host iron status on the outcome of malaria disease (Clark et al. 2014). However, it is important to note 
that the most basic questions of how iron directly affects the malaria parasite development remains 
unknown and under-investigated. Also, fundamental questions of how the Plasmodium acquires iron at 
the different stages during its life cycle and what is the source of iron that it uses, remain open. Most 
importantly, it is not known how is the signal of the iron levels in host transmitted into the parasite’s 
replication “decision”. Our focus was therefore directed to investigate the specific effect of iron 
perturbations on P. falciparum transcriptome.  
Throughout its life cycle, Plasmodium development is controlled by an amazing gene expression 
program allowing this unicellular organism to swap between two completely different hosts, travel and 
adapt to different cell types and to switch from a highly replicating asexual stage to a transmission sexual 
stage. It is scary and beautiful at the same time how extremely well adapted the parasite is to us; how it 
turns on and off specific genes accordingly to the most important cellular functions at a particular time 
of its development. Nothing is done by chance in Plasmodium.  
Transcriptional factors from the ApiAP2 family are emerging as the critical regulators of gene 
expression in Plasmodium, especially for their role in regulation of transitions between developmental 
stages, such as transition to form gametocytes, oocysts and liver stages. We identified several 
transcription factors from ApiAP2 family to be affected by our treatment conditions. An interesting 
result was that ApiAP2_2 (PF3D7_1317200) was up-regulated in Fe-treated samples, and that we found 
3 differentially expressed genes that contained specific binding sites for this transcription factor: another 
ApiAP2_3 (PF3D7_1429200) which was down-regulated in Fe-treated samples, the mRNA-binding 
protein PUF2 which was up-regulated with DFO and the histone methyltransferase SET4 which was 
down and up-regulated in Fe and DFO-treated samples, respectively. These evidences start to place this 
transcription factor as a potential master regulator, as it is regulating the expression of several genes 
affected by the Fe treatments, which by themselves regulate gene expression by post-transcriptional 
mechanisms. It is interesting to note that it is already described that the disruption of this transcription 
factor leads to the blockage in gametocyte production (Josling & Llinás 2015). It would be interesting 
to address if is there any link between disruption in iron levels and transcription control of gametocyte 
production. 
In addition to this transcriptional control, the gametocyte production is controlled post-transcriptionally 
by the RNA-binding protein PUF2 which works as a repressor of gametocyte production (Miao et al. 
2010). Therefore, it is interesting that we found PUF2 to be up-regulated with the DFO treatment. This 
provides another evidence supporting a relationship between iron levels and gametocyte production. 
Recently, the importance of translational regulation in gametocytes was discovered: by combining 
transcriptomic and proteomic data, Lasonder et al. observed that 512 highly expressed transcripts in the 
female gametocyte did not have the corresponding protein expression, showing a large scale 
translational repression in P. falciparum female gametocytes (Lasonder et al. 2016). Surprisingly, for 
some of these transcripts, the protein expression was only detected in oocysts and sporozoites, showing 
that repressed transcripts can be silenced for both short and long time periods. Based on our PUF2 result, 
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it would be of interest to further investigate the effect of iron on the translational regulation of sexual 
development of malaria parasites.  
Also, a component of the ubiquitin-proteasome system was affected by both the iron depletion and 
excess conditions, showing that the parasite might also be using this pathway as a way of tackling this 
stress situation. Iron-dependent degradation by the ubiquitin-proteasome pathway was already described 
as major player in the cellular iron homeostasis in human cells, through affecting the levels of IRP1 and 
IRP2, ferroportin and Hypoxia Inducible Factor (HIF) (Wang et al. 2007; Thompson & Bruick 2012; 
Vashisht et al. 2009). Therefore, it would be interesting to perform proteomic analysis of Plasmodium 
parasites developing in different iron conditions to gain better understanding of putative post-
transcriptional and post-translational iron regulatory mechanisms. 
An interesting finding from our RNA-seq analysis is change in expression of RUF6, a RNA of unknown 
function which was also affected by both conditions but in opposite directions. Is there the possibility 
that non-coding RNAs are involved in iron sensing and regulation? This was already observed in the 
cyanobacteria Synechostis, where several ncRNAs were identified as differentially expressed after an 
iron deprivation condition (Hernández-Prieto et al. 2012). In mice, it was shown that one liver-specific 
microRNA is involved in the regulation of expression of hepcidin mRNA and iron levels in the tissues 
(Castoldi et al. 2011). Thus, investigation of this RNA molecule in P. falciparum deserves further 
experimentation to understand its putative role in regulation of iron metabolism. Moreover, the 
expression of the histone-methyl transferase SET4 was affected by both iron conditions, shedding the 
light on a possible epigenetic mechanism of transcriptional regulation in response to iron, as it happens 
in Arabidopsis (Xing et al. 2015). It would be interesting to pursue which specific genes are target of 
this methylation. 
In addition to above mentioned putative gene expression regulators, several putative transporter genes 
and genes encoding enzymes involved in iron-consuming metabolic pathways, were also found 
differentially expressed between different iron treatments. The changes in expression of ATP11, a 
mitochondrial ATP synthase, highlight the possibility of some kind of metabolism reprograming. 
Additionally, it was already described that these proteins isolated from rat hearts have iron transport 
activity (Kim & Song 2010). Finally, haem transport and biosynthesis seem to play an important role in 
this process, as we identified two proteins involved in haem biosynthesis and a folate transporter (might 
be transporting haem?). It was already described the importance of haem synthesis, transport and 
degradation to hemozoin in Plasmodium (see Introduction, Iron in Plasmodium: what do we know?).  
It seems that the parasite not only adapt by changing its metabolism and transport system to overcome 
the changes in iron levels as we expected, but that it also reprograms its gene and protein expression 
systems. Thus, P. falciparum response to iron perturbations likely involves extremely complex and 
tightly regulated network of pathways that act downstream on a broad variety of target proteins (Fig 
5.1). As in other organisms, iron must be carefully regulated in order to be kept at a concentration high 
enough for the fulfilling of the cellular processes where it is involved, and avoid the formation of 
reactive oxygen species and toxicity by iron overload. 
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Regarding our approach, it is important to highlight the fact that by qPCR (and RNA-seq) we are 
measuring mRNA levels. Since the beginning of this work, we highlighted the importance of the post-
transcriptional layer of regulation in gene expression. It might be the case that for many genes their 
mRNA levels are not significantly altered between the different iron conditions, but that their 
translational efficacy is affected or that they are regulated at the protein-level. Therefore, integration of 
RNA-seq studies with other techniques such as proteomics would be useful in order to fill the most gaps 
possible and increase the probability of reaching valid conclusions. 
Some challenges were also faced during this work: it is obvious that when studying P. falciparum 
transcriptome, one must be aware of the strictly developmental regulation of gene expression. If the 
purpose is to study a specific stage during the intra-erythrocytic development, one must be completely 
sure that the parasites are exactly on the same stage between the biological replicates (since even 1-2 
hour differences can represent a great change in overall gene expression) by performing several rounds 
of synchronization. The safest approach might be to start parallel cultures from one initial synchronized 
culture and study the transcriptome on different time-points during development (as the studies from 
Llinas, Bozdech and Otto described in the Introduction). The major issue with this approach is the cost 
of RNA-seq analysis. As the sequencing protocols are becoming a common approach and essential part 
of almost every scientific project, the drop in the cost will in future allow the increase in the number of 
replicates and conditions. These approaches are important to identify missing genes involved in iron 
Figure 5.1 – Plasmodium falciparum putative iron-responsive network: our findings indicate that the parasites does not rely 
on a simple alteration in the expression levels of iron transports or proteins directly involved in iron but in a broader system 
including transcriptional, post-transcriptional and epigenetic regulation, as well as ncRNAs, metabolism, haem biosynthesis 
and proteasome dependent protein degradation. It is undeniable that the parasite has a highly complex network of iron 
regulation, involving several layers of control, showing the importance of the maintenance of iron homeostasis for P. 
falciparum.    
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regulation and metabolism in P. falciparum which do not share a substantial percentage of sequence 
identity with iron-responsive genes in other organisms. 
Approximately half of P. falciparum genes possess introns, making an isoform differential expression 
analysis in the different iron conditions an attractive approach. This would show if the alternative 
splicing is another mechanism involved in iron homeostasis, as it is in proliferation inside RBCs (Eshar 
et al. 2012). Ideally, we would have proteomic data to complement and increase the reliability of our 
findings. Also, we consider that if we analyse the transcriptome response to our iron treatments in 
different time points of the blood stage, we would be able to see how the iron regulation is coordinated 
with the life cycle progression. Experiments in liver stage would be also useful, as the iron metabolism 
of the parasite at this stage is unknown and highly under-investigated. 
Several interesting studies could be performed based on our findings, that would increase our 
understanding of the iron biology of the parasite, and consequently in its basic biology: it would be of 
great relevance to compare the transcriptome of P. falciparum parasites collected from anaemic and 
non-anaemic patients (possibly resembling our iron depletion and excess condition, respectively). 
Another highly informative experiment would be to put the blood of these patients on culture with our 
iron treatments and study the transcriptome before and after the treatments, to observe the adaptation of 
the parasite to the different iron environments and try to revert the gene expression program only with 
iron fluctuations. If we were able to understand the parasite iron adaptation and predict when and how 
it will do it, we will be able to design more powerful therapies, combining drug administration with iron 
supplementation. 
The work developed throughout this thesis had the major objective of ironing out the mechanisms behind 
iron homeostasis during the blood stage of P. falciparum parasites. Obviously, it represents a huge 
challenge which should be approached from several directions and using multiple strategies. However, 
we were able to observe that blood stage P. falciparum responds to environmental iron changes by 
mounting a transcriptomic response. The analysis of this response indicates that this parasite does not 
rely on a single mechanism of iron regulation, but that in fact a highly complex network of pathways 
act on different fronts, starting with the gene and protein expression regulation and extending to 
metabolic pathways. We consider that we were able to broaden the horizons of the iron sensing and 
regulation in the malaria parasite, and opened doors for multiple new hypothesis which are relevant to 
pursue.  
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Supplementary information 
 
Table S1 – Raw sequence data statistics of each sample. 
Sample ID 
Number of bases 
(Mbp) 
Number of reads Mean read length 
Sample 1 - C1 1460 14 643 906 101 
Sample 2 - Fe1 3290 30 290 286 101 
Sample 3 - Aa1 2530 25 274 096 101 
Sample 4 - DFO 1 4751 48 249 776 101 
Sample 5 - C2 2686 26 872 596 101 
Sample 6 - Fe2 2591 25 935 940 101 
Sample 7 - Aa2 2586 25 901 590 101 
Sample 8 - DFO2 2587 25 895 234 101 
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Figure S1 – Plot containing the average quality at each cycle. Top row, sample 4 DFO1; Bottom row, sample 7 AA2; 
Yellow box: interquartile range (25-70%) of Phred score at each cycle; Red line: median of Phred score at each cycle; Blue 
line: average of Phred score at each cyle; Green background: good quality (Phred score > 28); Yellow background: acceptable 
quality (20 < Phred score < 28); Red background: bad quality (Phred score < 20); x-axis: number of cycles; y-axis: Phred 
quality score 
DFO1 
Forward read 
 
Reverse read 
      AA2 
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Table S2 – List of primers used for qPCR. 
  Gene P. falciparum ID 
Forward TGTTCATACGCTCATTCACC 
Cth2 PF3D7_1134600 
Reverse GTGCCCTTAATTCTAGTTCTCC 
Forward GAGGTGTTACATAGTAGAACGC 
Cth1 PF3D7_0906600 
Reverse TCATTATTACTACTTTCCCTTCCC 
Forward CTCAATGTAAATTTAGTAATGCC 
Grx4 PF3D7_0606900 
Reverse ATATAATTGTGGATATGTAGGC 
Forward TATCAATGTATGGAAGCTACGC 
Tyw1 PF3D7_0524900 
Reverse TGCTTTATCCATATTCCATCTCC 
Forward CATTAGATAAGGCTCTTGATGC 
Tsa1 PF3D7_1438900 
Reverse ATGTATGTTGGATATTTCCTATACC 
Forward CACTGAACTTGCTGAATTTGG 
Prx1 PF3D7_0802200 
Reverse AATATCCCACTTATCTAGGTTTCC 
Forward ATCACAGGAGCAATTTCTGG 
Mrs3 PF3D7_1241600 
Reverse CTCGGATCATAAATGGAGAAGG 
Forward AAGACAAGAGTCCTCACC 
Mrs4 PF3D7_0905200 
Reverse CTATACCGCCACCTATTCC 
Forward TGGTATGAGATATGGAGAAAGG 
Ferrochelatase PF3D7_1364900 
Reverse CTGCTGATTGTGGATATAATGG 
Forward TCCGCCTATGTTGCATATAC 
VIT PF3D7_1223700 
Reverse GTAAATTGTGACTTGAACAATCC 
Forward TGGACATGTGACTGGACTTGA 
DMT PF3D7_0523800 
Reverse CTTGAATATGAGCACCCCAAA 
Forward GACACTCTTTCACAACATATAACA 
ZIP1 PF3D7_0609100 
Reverse GAATAGCCAAAGAGATGGTTA 
Forward GAAGGCTTACTTATGGGAAG 
ZIP2 PF3D7_1022300 
Reverse GCTTGCTAGTAAAGGATTTTCTA 
Forward GTTAGCAAATATATTTATGGCA 
ZIP3 PF3D7_0715900 
Reverse GTTGAAAAATTCTTCTTAACACT 
Forward CAAATCGGCCCTCTCTTA 
CuTP PF3D7_0904900 
Reverse GTATCTTCCGTTTTTGGCA 
Forward GCTCGTTATCACCAGGTTC 
IRP PF3D7_1342100 
Reverse CTTCATCTAGGTGCCCACT 
Forward GGAAACCTTGTTACGACTTCTCC 
18S rRNA PF3D7_1148600 
Reverse TGCTATGCTGCCTGCTCTTA 
Forward AAGTAGCAGGTCATCGTGGTT 
Serine tRNA ligase PF3D7_0717700 
Reverse TTCGGCACATTCTTCCATAA 
Forward GACATAAGTTTAGTAGGTCG Inositol 5-phosphatase PF3D7_0802500 
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Reverse TTCTGACTCCACATCATTTG 
Forward GGAAATCCATAGACAAACAATG Adenyllocusccinate lyase 
(ASL) 
PF3D7_0206700 
Reverse TCCTGTGAGAAGTGCTCCAC 
Forward GTTGCTGTCATCCAATAA 
ZF1 PF3D7_1407700 
Reverse TGGGAAGTTTCGGTAAT 
Forward TTCGTACGGTTTACATAAC 
ApiAP2_1 PF3D7_0404100 
Reverse CCATATCCTGTGTATCATATC 
Forward GTTTCCATAAACCTGATTTG 
ApiAP2_2 PF3D7_1317200 
Reverse CTACACCCTTATGATCTTTC 
Forward AACGGAGAAATGGAAGA 
ApiAP2_3 PF3D7_1429200 
Reverse CCTTCCTGTAACTTCTCTA 
Forward AGAACCATACGTTCCTC 
DBP PF3D7_1231300 
Reverse TTTGGACAAGCACAAAG 
Forward GTGTAGAAGTATTACCATGTAG 
PUF2 PF3D7_0417100 
Reverse GTTGCTCGTTTCCTATTT 
Forward GTCGTTAGGTATGTAACCTTTC 
RUF6-2 PF3D7_0711800 
Reverse GGGTAACTCAGCAGCTC 
Forward AACGAAACGCACATAAA 
SET4 PF3D7_0910000 
Reverse GTGTATGCTATATCAGAAGG 
Forward ACAAGCCATTCTCTATAAC 
UbE1 PF3D7_1350400 
Reverse GCCAGTGATTCAATAATTC 
Forward CCTTGTTCTCGTGATTTA 
ATP11 PF3D7_1209800 
Reverse CTTTCTAATAAGGGCAACT 
Forward GAGAGTTATTCGAGTGATAC 
ABCF1 PF3D7_0813700 
Reverse GTTCTGTTCCGTTTGTT 
Forward GTATCCTACCCAGACATAA 
MgT1 PF3D7_0827700 
Reverse ATACACCATTCTGCTTTG 
Forward GGAAGGTTCTTACAATCTAT 
MgT2 PF3D7_1467000 
Reverse TTGCTCTTTCCTCTTCT 
Forward CTTCTCTTAGCATCGTTATG 
FT1 PF3D7_0828600 
Reverse TCGATATCCGAAGATTGG 
Forward TCATCATCTATAAGCACATC 
TePy PF3D7_1247600 
Reverse CTTGTTGGGTATCGTAAC 
Forward CTTTAACTTCCTTTCTAGGT 
Farnesyltransferase PF3D7_0519300 
Reverse GATCCTACAATTGATCCTAC 
 
